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(Under the direction of Brian Pietrosimone)  
 
 
 Context: Appropriate biomechanical loading is necessary for maintaining cartilage health 
following an anterior cruciate ligament reconstruction (ACLR) to prevent post-traumatic knee 
osteoarthritis (PTOA), yet the optimal amount of joint loading to mitigate joint tissue changes 
following ACLR is unknown. Peak vertical ground reaction force (vGRF) during a single step 
associates with biomarkers of joint tissue metabolism, femoral cartilage composition, and patient 
reported outcome (PROs) following ACLR. However, it remains unknown how daily steps, time 
in moderate to vigorous physical activity (MVPA), and cumulative loading (i.e. the product of 
peak vGRF and daily steps) associate with PTOA outcomes. Objective: To determine the 
associations between physical activity, cumulative loading, and PTOA symptoms and pathology 
following ACLR. Methodology: PROs were collected on individuals with unilateral primary 
ACLR. Daily steps and time in MVPA were objectively measured using an accelerometer, which 
participants wore for seven days. Cumulative loading was calculated as the product of daily steps 
and vGRF, measured using a force plate. Cross-sectional area (CSA) of femoral cartilage using 
ultrasound and serum cartialge oligomeric matrix protein (COMP) were collected both prior to 
and immediately following a 3000-step protocol to measure change in COMP (%ΔCOMP) and 
change in CSA (%ΔCSA). Resting serum COMP, resting serum matrix metalloproteinase-3 
(MMP-3) and T1rho magnetic resonance imaging (MRI) relaxation times of femoral cartilage in 
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the involved limb were collected. Main outcome measures: Separate univariate linear 
regression analyses were conducted to determine the unique change in R2 (∆R2) between the 
dependent variable and independent variable after accounting for covariates. Independent 
variables were daily steps, MVPA, and cumulative loading and the dependent variables were 
PROs, %ΔCOMP, %ΔCSA, resting COMP, resting MMP-3, and T1rho MRI relaxation times. 
Results: Daily steps, MVPA, and cumulative loading did not associate with PROs, %ΔCOMP, 
or %ΔCSA. Greater time in MVPA associated with greater resting MMP-3 and greater T1rho 
MRI relaxation times. Conclusions: Excessive time in MVPA may associate with biomarkers of 
cartilage breakdown and proteoglycan depletion. The results of the current study suggest the 
need for longitudinal studies that evaluate physical activity and cumulative loading in individuals 
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CHAPTER 1: INTRODUCTION 
The relationship between biomechanical loading and post-traumatic knee osteoarthritis 
(PTOA) symptoms and pathology is not well understood  
 
 Post-traumatic knee osteoarthritis (PTOA) is a condition that affects approximately two-
thirds of all individuals who undergo anterior cruciate ligament (ACL) injury and ACL 
reconstruction (ACLR) within two decades of initial injury (1). Approximately 100,000 ACLR 
surgeries are performed annually (2), adding to the $3.06 billion spent annually in the United 
States health to treat PTOA (3). Overall, individuals with PTOA account for 12%, or 5.6 million 
individuals, of all symptomatic osteoarthritis cases in the United States (3). A systematic review 
(1) found the prevalence of PTOA in patients who underwent ACLR (44%) was slightly greater 
than those who remained ACL deficient (37%), suggesting ACLR may not mitigate the risk of 
PTOA (1, 3, 4). Therefore, development of rehabilitative interventions and treatments are needed 
to delay or prevent onset of PTOA.   
 Originally described as a wear and tear disease characterized distinctly by the loss of 
articular cartilage, it is now known PTOA development is a much more complex condition (5). It 
is hypothesized that overall knee joint homeostasis is influenced by biomechanical signals from 
whole body biomechanics such as walking (6, 7), which then influences the biological 
environment of the articular cartilage and surrounding tissues (8). Aberrant kinematics and 
kinetics during gait can alter the metabolic and inflammatory processes occurring at the knee 
joint (8–10). Individuals post-ACLR demonstrate alterations in walking gait biomechanics, and it
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is likely that this change in cyclical biomechanical loading of the joint influences alterations in 
articular cartilage biology, composition, and ultimately structure (5, 8). Therefore, it is of high 
importance to create interventions that can restore a normal biomechanical loading environment 
to maintain joint homeostasis. However, it is still unknown what amount of biomechanical 
loading is optimal for the knee joint following injury. A critical step in understanding the 
pathogenesis of PTOA and developing new therapies to prevent PTOA is to determine how 
biomechanical loading, specifically total exposure to biomechanical loading based on step 
frequency and physical activity, influences symptoms and pathology of PTOA following ACLR.  
 
Gap in the literature: The influence of the magnitude of biomechanical loading on PTOA 
outcomes is well documented, but the influence of the frequency of biomechanical loading 
remains unknown. 
 
 While studies have demonstrated walking gait biomechanical variables associate with 
symptoms and pathology of PTOA, most previous studies have focused on the magnitude of 
joint or extremity loading during a single step. It is unknown how the frequency of loading in 
real-world situations influence PTOA related outcomes. Individuals with ACLR take 
approximately 8,500 daily steps (11), and the amount and contact area on the cartilage surface of 
loading may influence biomechanical properties of the cartilage (8, 12, 13). Fluctuations in step 
frequency or the amount of physical activity throughout a day, week, or month, may alter 
articular cartilage biology and metabolism, potentially leading to changes in articular cartilage 
composition and structure. Additionally, any small alterations in the magnitude of a kinematic or 
kinetic gait variable over a single step may be exacerbated over the course of the day depending 
on the frequency of loading. For example, cumulative knee adduction moment was better than 
knee adduction moment measured in a single step at predicting which individuals had knee 
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osteoarthritis vs. non-pathological knees (14). Therefore, it is important not only to monitor 
physical activity and step count, but also to measure biomechanical variables cumulatively, in 
order to understand the total exposure of the joint to loading following ACLR. Prior to 
development of rehabilitative interventions that may alter biomechanical loading, it is crucial to 
understand how step frequency, physical activity, and total exposure to loading influence PTOA 
symptoms and pathology. 
 
Measuring physical activity and cumulative loading may provide missing information on 
the link between biomechanical loading and PTOA symptoms and pathology. 
 
 Most biomechanics studies following ACLR have evaluated walking gait biomechanics  
by averaging approximately five steps collected using laboratory equipment (15, 16). While this 
information is important for evaluating joint biomechanics, the overall loading placed on the 
knee joint tissues also depends on the number of steps as well as the magnitude of load exerted 
on tissues of the joint. Previous studies have demonstrated peak vGRF during the first 50% of 
stance phase of walking gait explains 28% of the variance in serum type-II collagen turnover (9) 
and 14-24% of the variance in MRI measures of proteoglycan density throughout different 
weight-bearing regions of tibiofemoral articular cartilage (17). Large amounts of variance in 
these PTOA outcomes of symptoms and joint health are still not explained, and this may be 
because the frequency of loading throughout a day, week, or year is not measured. Evaluating 
loading repetition is critical to understanding the relationship between biomechanical loading 
and articular cartilage biology (18).  
 Cumulative loading is an approach that utilizes the product of daily steps and an 
important walking gait biomechanical variable, such as peak vGRF in the first 50% of stance 




(1) Cumulative Loading = daily steps x peak vGRF   
 
Cumulative loading has been used previously to distinguish between healthy and osteoarthritic 
knees, using the variables knee adduction moment and daily steps (14). In addition to lesser knee 
moments and tibiofemoral contact forces compared to uninjured controls (19), individuals with 
ACLR also demonstrate lesser daily steps and minutes spent in moderate to vigorous physical 
activity (MVPA) compared to controls (11). This indicates that overall biomechanical loading as 
well as physical activity may be an important variable that is decreased following ACLR. In 
order to develop interventions that restore normal biomechanical loading following ACLR, we 
need to study the relationship between cumulative loading and physical activity with PTOA 
development in order to determine optimal biomechanical loading following ACLR.   
 Following ACLR, biomechanical alterations in walking gait shift the load-bearing contact 
locations of the joint to a new, previously unloaded region of articular cartilage (8). Additionally, 
changes in knee joint kinetics and kinematics following injury alter the amount of contact force 
and biomechanical load placed on the knee joint (19). Areas of tibiofemoral articular cartilage 
that experience these greater contact forces are generally thicker than areas that do not undergo 
as much biomechanical loading (20, 21). Shifting the tibiofemoral contact area to a thinner, 
previously unloaded region may initiate degradation of articular cartilage (8, 12, 22). Many 
walking gait biomechanical variables are altered following ACLR (15, 16); however, vertical 
ground reaction force (vGRF) is a fundamental measure of load exerted during stance (23) and 
inherently influences kinetic measures, as well as tibiofemoral contact forces. Greater peak 
vGRF in the first 50% of stance associates with better patient-reported outcomes (PROs) (24, 
5 
 
25), lesser type-II collagen turnover (9), lesser inflammation and degenerative enzymatic activity 
(10), greater proteoglycan density (17), and thicker medial femoral condyle cartilage (26) in 
individuals post-ACLR. Peak vGRF in the first 50% of stance is a variable that associates with 
PTOA symptoms and pathology, and therefore may be a potential variable to use to measure 
cumulative loading. 
 
PTOA symptoms should be evaluated separately from pathology and differences in 
biomechanical loading exist between asymptomatic and symptomatic individuals post-
ACLR. 
 
 In order to comprehensively evaluate PTOA development, it is necessary to evaluate both 
PTOA symptoms as well as the pathology. Symptomatic KOA is defined by articular cartilage 
loss as well as the presence of pain, aching or stiffness in a joint or disability related to 
symptoms in the joint (27). The Knee Injury and Osteoarthritis Outcome Score (KOOS) is a 
commonly used PRO that assesses patient perception regarding the knee in 5 different 
categories: pain, symptoms, activities of daily living (ADL), sport/recreation and quality of life 
(QOL) (28). The KOOS has also been used to dichotomize patients as symptomatic vs. 
asymptomatic (29). Approximately, 43% (N=1530) and 39% (N=1506) of the individuals 
enrolled in the Multicenter Orthopedic Outcomes Network (MOON) Knee Project cohort were 
symptomatic at 2 and 6 years following ACLR, respectively (30). 39-43% of individuals post-
ACLR demonstrate clinically relevant symptoms, which is similar to the percentage of 
individuals post-ACLR who go on to develop radiographic PTOA (1). It is important to study 
asymptomatic and symptomatic cohorts separately, as individuals without symptoms may 
demonstrate different biomechanics and loading profiles compared symptomatic individuals. For 
example, asymptomatic individuals demonstrate differences in vGRF throughout stance 
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compared to symptomatic individuals with ACLR (24). Additionally, worse KOOS scores 
following ACLR associate with lower amounts of subjectively measured physical activity (30). 
The KOOS questionnaire is a commonly used PRO, which associates with outcomes of general 
health (31) as well as walking gait biomechanics following ACLR (24, 25). When evaluating 
PTOA development, the KOOS questionnaire is an excellent tool to assess symptoms (28). 
While it is known PTOA symptoms alter vGRF throughout stance phase of a single step (25), it 
is unknown if PTOA symptoms influence physical activity and cumulative loading in individuals 
post-ACLR. It is important to know if symptoms influence physical activity and cumulative 
loading because symptoms may limit an individual’s ability to complete physical activity, and 
the relationship between physical activity and patient reported function may be different 
depending on if a person is symptomatic or asymptomatic.  
 
Biochemical markers and imaging outcomes are crucial for evaluating early changes in 
PTOA pathology that cannot be evaluated with radiographic imaging. 
 
 In addition to addressing symptoms of PTOA, it is crucial to evaluate outcomes of PTOA 
pathology that are indicative of articular cartilage biology, morphology, and composition in order 
to identify deleterious changes in articular cartilage before they are irreversible. While KOA is 
most often diagnosed utilizing radiographic images of joint space narrowing and osteophyte 
development (32), radiographic images only evaluate structural changes. By the time articular 
cartilage degradation is visible on radiographs, the structural damage is likely irreversible, 
therefore measures that can evaluate early changes in articular cartilage are needed. Biochemical 
markers (such as markers of inflammation, degenerative enzymatic activity, and type-II collagen 
turnover) and advanced imaging such as ultrasound (US) and magnetic resonance imaging (MRI) 
can provide methods to evaluate PTOA pathology before irreversible changes in articular 
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cartilage structure take place. Studies have demonstrated that vGRF associates with biochemical 
markers of joint tissue metabolism as well as inflammation and degenerative enzymatic activity 
in individuals with an ACLR (9, 10). These markers provide information about the metabolic and 
inflammatory environment of the articular cartilage and can detect changes in the cartilage 
within one day following ACL injury before changes have occurred in cartilage composition 
(33). Biochemical markers of cartilage metabolism and composition are outcome measures that 
can detect changes in articular cartilage before irreversible cartilage loss. When evaluating 
response to biomechanical loading, we can determine if biomechanical loading associates with 
processes of cartilage metabolism and composition and make changes to biochemical loading 
before irreversible cartilage damage occurs.  
 
Advanced imaging with MRI and US can evaluate changes in articular cartilage 
composition, which occurs following alterations in articular joint tissue metabolism but 
prior to structural changes.  
 
 T1rho MRI is sensitive to interactions between water and macromolecules, such as 
proteoglycans (34), and T1rho relaxation times have been found to correlate with depleted 
proteoglycan density in bovine (35) and human articular cartilage (36). Decreased proteoglycan 
density of the articular cartilage is associated with early osteoarthritis progression (37), and 
therefore decreased proteoglycans may be indicative of worse articular cartilage following 
injury. Compared to MRI, US is a more cost effective and clinically accessible to monitor 
changes in cartilage morphology. In uninjured controls, femoral articular cartilage cross-
sectional area (CSA) deforms following walking (38, 39), and the amount of change in CSA 
could be indicative of cartilage composition. Changes in CSA measured with US could provide 
important information regarding articular cartilage’s ability to absorb and resist biomechanical 
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loading at the knee joint post-ACLR. Studies have shown that peak vGRF in the first 50% of 
stance associates with both T1rho MRI (17) as well as femoral cartilage CSA measured with US 
(26). However, it is still unknown if cartilage composition associates with physical activity and 
cumulative loading. In order to comprehensively evaluate outcomes of PTOA pathology, it is 
important to measure markers of cartilage biology as well as composition. The current study will 
use multiple modalities to measure joint tissue metabolism via serum measurements as well 
cartilage composition using MRI T1rho relaxation times and change in femoral cartilage CSA 
following a standardized walking protocol. 
 
Gaps in the literature regarding cumulative loading and physical activity will be answered 
in the current study. 
 
 While it is known whether lesser peak vGRF associates with PTOA symptoms and 
pathology, there is still a large amount of unknown variance in how biomechanical loading 
influences these PTOA outcomes. Determining if daily steps, MVPA, and cumulative loading 
associate with PTOA symptoms and pathology will provide crucial information for determining 
optimal biomechanical loading post-ACLR. The current study will propel future rehabilitation 
and treatment options for restoring normal biomechanical loading and potentially mitigating 
PTOA symptoms and delaying PTOA pathology. Therefore, the purpose of this study was to 
determine if there is an association between daily steps, MVPA, cumulative loading and 






 Gap in the literature: Peak vGRF is associated with PROs and is different between 
symptomatic and asymptomatic individuals post-ACLR (24). It is unknown how physical 
activity and cumulative loading are influenced by symptoms of PTOA. 
 Specific Aim 1: The primary aim was to determine the association between daily steps, 
time spent in moderate to vigorous physical activity (MVPA), and cumulative loading 
(Cumulative loading = daily steps x peak vGRF) with patient-reported outcomes (PROs) in 
individuals post-ACLR. The secondary aim was to separately determine these associations 
within asymptomatic and symptomatic individuals post-ACLR. Daily steps and MVPA was 
objectively measured using an accelerometer, which participants wore for seven days. 
Cumulative loading was calculated as the product of daily steps and vGRF, measured using a 
force plate located in the laboratory. PROs were collected the same day as vGRF. Time from 
ACLR and age were collected at the same time as PROs and were included as covariates in the 
regression analyses. I hypothesized that greater daily steps, time in MVPA, and cumulative 
loading would associate with better PROs in individuals post-ACLR. I hypothesized that greater 
daily steps, greater MVPA, greater cumulative loading and better PROs would associate more 
strongly in symptomatic individuals than in asymptomatic individuals. 
 Gap in the literature: Peak vGRF associates with changes in COMP (40) and femoral 
cartilage cross-sectional area (26). It is unknown how physical activity and cumulative loading 
influence outcomes of PTOA pathology. 
  Specific Aim 2: Determine the association between daily steps, MVPA, and cumulative 
loading with cartilage deformation and change in serum COMP following a standardized loading 
protocol in individuals between 6-18 months following ACLR. Daily steps, MVPA, and 
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cumulative loading was collected as described in Aim 1. Cross-sectional area of femoral articular 
cartilage was collected using US both prior to and immediately following a 3000-step loading 
protocol on the same day in the laboratory. Walking speed was collected and included as 
covariates in the regression analyses. I hypothesized that greater daily steps, greater MVPA, and 
greater cumulative loading would associate with greater cartilage deformation and lesser change 
in COMP following a standardized loading protocol in individuals 6-18 months following 
ACLR. Sex influences associations between biochemical markers of joint tissue metabolism and 
body mass index (41) and months between ACL injury (42). Therefore, an exploratory secondary 
purpose of this study was to determine the associations between daily steps, MVPA, and 
cumulative loading and greater cartilage deformation and change in COMP following a 
standardized walking protocol separately in males and females. 
 Gap in the literature: Greater peak vGRF in the first 50% of stance associates with lesser 
concentrations of biomarkers of joint tissue metabolism (9) and T1rho MRI relaxation times (17) 
in individuals with ACLR; however, it is unknown how physical activity and cumulative loading 
associate with joint tissue metabolism and cartilage composition following ACLR.  
 Specific Aim 3: Determine the association between daily steps, MVPA, and cumulative 
loading and biomarkers of joint tissue metabolism and T1rho MRI measures of cartilage 
composition in individuals between 6-18 months following ACLR. Daily steps, MVPA, and 
cumulative loading were collected as described in Aim 1. Biochemical markers of joint tissue 
metabolism from resting serum samples were collected on the same day in the laboratory. 
Resting MRI of the involved limb were collected on a separate day within 4-weeks of all other 
measures collected. T1rho MRI relaxation times were evaluated within weight bearing regions of 
interest of femoral articular cartilage. Age was also collected and used as a covariate in the 
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regression analyses. I hypothesized greater daily steps, greater MVPA, and greater cumulative 
loading will associate with lesser biomarkers of joint tissue metabolism and cartilage 




CHAPTER 2: LITERATURE REVIEW 
I. Post-Traumatic Knee Osteoarthritis Following Anterior Cruciate Ligament 
Reconstruction 
 
A. Epidemiology  
 Knee osteoarthritis (KOA) is a very common condition, with a global prevalence of 
radiographically confirmed symptomatic KOA of 3.8% (43). This number is higher in females 
(4.8%) and increases with age (43). About 13% of women and 10% of men aged 60 years and 
older have symptomatic KOA (27). Hip and KOA, of which KOA is more common, are the 11th 
highest contributors to global disability measured in 2010, compared to the 15th biggest 
contributors in 1990 (43). KOA is an economic burden for individuals who must adapt their lives 
to live with the disease or who experience lost work productivity as a result of disability (44). 
Patients with KOA are at a higher risk of death compared to the general population by an odds 
ratio of 1.54 (45), and KOA generally presents at an earlier age compared with other types of 
osteoarthritis (45). Systemic risk factors for KOA include genetic predisposition, age, female 
gender, race, congenital conditions and diet (27). Local risk factors for KOA include obesity, 
occupation, physical activity, biomechanical factors such as muscle imbalances or weaknesses, 
alignment issues, knee laxity and traumatic knee injury and resulting surgery (27). Multiple 
studies (46–48) have noted obesity and previous knee trauma are two of the main predictors of 
KOA incidence as well as progression. 
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 The development of KOA as a result of injury to the synovial joint is a phenotype of OA 
known as PTOA (3). Although there are many similarities between PTOA and idiopathic KOA, 
the primary difference is that patients with PTOA normally experience a well-defined impact to 
the knee joint such as an articular fracture, chondral injury, or ligament or meniscal tear (49, 50). 
The age of PTOA onset is much younger relative to individuals with idiopathic KOA, as these 
traumatic knee injuries tend to occur in youth and young adults, particularly ages 15-25 (4, 51). 
PTOA develops more rapidly than idiopathic KOA, with changes in articular cartilage 
composition occurring within one year following injury (36). Initial damage from injury and 
surgery as well as changes in loading (52, 53) and physical activity (11) may all lead to the rapid 
deleterious alterations in articular cartilage composition observed within one year following knee 
injury.  Individuals with PTOA account for 12%, or 5.6 million individuals, of all symptomatic 
OA cases in the United States (3).  Approximately 60% of all individuals who undergo ACLR 
develop radiographic KOA within 2 decades of injury (1, 4). Rapid development of PTOA at a 
younger age may result in joint replacement earlier in life and contributes $3.06 billion annually 
to United States health care costs (3). Those with PTOA who undergo joint replacement also 
experience worse outcomes and greater risk of complication than those with idiopathic KOA 
(54)(55). The large economic and social burden of PTOA in the United States warrants future 
research aimed at treatment of PTOA symptoms and, perhaps more importantly, interventions 
aimed at PTOA prevention early following ACLR.  
 
B. Post Traumatic Knee Osteoarthritis Pathology 
 Osteoarthritis is defined both pathologically as a condition and clinically as an illness 
(56). The reference standard for pathologically defining KOA is the Kellgren-Lawrence grading 
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scale, using a radiographic image of the knee joint. This scale defines the severity of the disease 
on a scale of 0 to 4, based on joint space narrowing, sclerosis, cysts, and deformities (32). 
Radiological features including formation of osteophytes on the joint, periarticular ossicles, 
narrowing of joint cartilage associated with sclerosis of subchondral bone, small pseudocystic 
areas with sclerotic walls and altered shape of the bone ends were examined to diagnose 
osteoarthritis (32). Radiographic images offer a high contrast resolution for bone, but they cannot 
directly visualize non-ossified structures such as articular cartilage, menisci, ligaments, synovial 
fluid, or tendons and muscles; therefore, x-rays lack the scope required to assess the entire 
synovial joint (57). More current methods using advanced imaging modalities may offer a more 
complete diagnosis and evaluation of the pathology of KOA.  
 More advanced modalities of evaluating KOA pathology include magnetic resonance 
imaging (MRI) and ultrasound (US). While radiographs are used to evaluate the knee joint as a 
structure, other newer imaging techniques can estimate the composition and morphology of 
articular cartilage and other structures in the knee joint and are more sensitive methods to 
evaluate deleterious changes in the joint. MRI can discriminate articular tissues, such as articular 
cartilage, menisci, and ligaments, and therefore can evaluate the knee joint as a whole (57). 
Specifically, MRI T1rho relaxation time can be used to evaluate water content, which is 
indicative of proteoglycan density in the articular cartilage (34). Other measures such as 
biochemical markers are used to evaluate and monitor changes in cartilage biology, which can be 
affected prior to changes in composition (8). While older methods could only evaluate the 
structure of ossified bones that make up the knee joint, more advanced modalities can measure 
changes in biology and composition of multiple tissues in the synovial joint, which is a very 
important step for understanding the pathogenesis of KOA. 
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 Originally described as a wear and tear disease characterized distinctly by the loss of 
articular cartilage, it is known now the KOA is a much more complex process that affects the 
entire synovial joint. However, the exact pathogenesis of the development of KOA is still 
unknown, likely because the number wide and diverse risk factors associated with KOA suggest 
there are multiple pathways to the disease (5). It is theorized that biological, structural, and 
biomechanical components are all involved in the development of KOA (5). Specific to PTOA, 
the KOA process is initiated with a traumatic knee injury, such as an ACL tear and ACLR. Prior 
to structural changes visible in radiographs, the biological structure of synovial tissues in the 
knee change as a result of the injury itself (58). Studies utilizing biochemical markers have 
demonstrated upregulation of proinflammatory cytokines (59) as well as degenerative enzymatic 
activity (33) in the synovial tissue immediately following ACLR. Inflammation and degenerative 
activity likely occurs in order to breakdown type-II collagen and proteoglycan proteins damaged 
during injury and to synthesize new and healthy macromolecules in the cartilage (60). Degraded 
proteoglycan (59) proteins as well as matrix proteins that help stabilize the articular cartilage 
structure (61), are all elevated in synovial fluid within six months following injury. Evidence 
suggests that biological changes in articular cartilage and synovial tissue biology occur within 
days of ACL injury and ACLR (62).  
 Alterations in articular cartilage biology may continue as an individual moves further out 
from ACL injury and ACLR, likely due in part to alterations in biomechanical loading of the 
joint (5, 9, 10). Studies show elevated T1rho relaxation times, associated with lesser 
proteoglycan density, in ACLR tibiofemoral articular cartilage compared to the uninvolved 
contralateral limb one year following ACLR (36, 63). Elevated T1rho relaxation times in the 
involved limb still persist 2 years following ACLR compared to uninjured controls (64). It is 
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hypothesized that these early cartilage abnormalities are indicative of early compositional 
changes, i.e. decreases in proteoglycan content and disorganization of type-II collagen consistent 
with PTOA development (64). New MRI techniques are being used to evaluate the interplay 
between mechanics of the knee joint and compositional changes in the articular cartilage (17, 
65). These changes in articular cartilage biology immediately after ACLR followed by 
compositional changes within one year following ACLR are hypothesized to lead to irreversible 
structural changes in the knee joint, i.e. articular cartilage loss (5).  
 
C. Post Traumatic Knee Osteoarthritis Clinical Symptoms 
 Not all persons with radiographic KOA have clinically relevant symptoms of KOA, or 
symptomatic KOA (66). Several studies have determined only a weak association between 
symptoms and radiographic severity of KOA (67). However, there is a significant correlation 
between continued narrowing of the joint space width and worsening of symptoms (68). Middle-
aged women are an exception, showing a strong correlation between pain and severity of 
cartilage defects (69). Bedson et al. (67) found that those with knee pain symptoms who were 
diagnosed with radiographic KOA ranged from 15-76%, and those with radiographic KOA with 
knee pain symptoms ranged from 15-81%.  
 Symptomatic KOA is generally defined by the presence of pain, aching, or stiffness in a 
joint or disability related to symptoms in the joint (70). Patient reported outcomes (PROs) 
provide a standardized and clinically feasible method of determining a patient’s symptoms and 
function that omits observer bias (28). The Knee Injury and Osteoarthritis Outcome Score 
(KOOS) is a commonly used PRO that assesses the patients’ opinion about their knee and 
associated problems (28). The KOOS is separated into five subscales that evaluate pain, 
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symptoms, activities of daily living (ADL), sport/recreation and quality of life (QOL). PRO’s, 
specifically KOOS, taken at baseline are highly predictive of follow-up PROs at 2, 6 and 10 
years following ACLR (71, 72). Large multicenter studies have found risk factors for poor PRO 
scores in individuals with an ACLR include ipsilateral knee injury (30) high body mass index 
(71, 73), lower self-reported physical activity (30) and concomitant injuries at the time of ACLR 
(71, 72). PROs are a clinically feasible tool that provides a subjective measure of the patient’s 
symptoms and functional ability early following ACLR that correlate to several risk factors of 
KOA. 
 Although there is a discrepancy between idiopathic KOA symptoms and radiographic 
evidence, new studies suggest an association between worse symptoms, altered walking gait 
biomechanics (24) and worse proteoglycan content in the articular cartilage (74) one year 
following ACLR. Additionally, lower PROs 2-years following ACLR were associated with 
elevated T1rho relaxation times 5-years following ACLR (75). The positive relationship between 
PROs and articular cartilage composition indicates that both measurements of symptoms and 
cartilage structure are extremely important when monitoring changes in the knee joint following 
ACLR.  
 
II. Loading during Walking Following Anterior Cruciate Ligament Reconstruction 
A. Kinetics and Kinematics Within One Year Following ACLR 
 While in the past KOA was described as a wear and tear condition, it is now known that 
the pathology is much more complex. PTOA is initiated when otherwise healthy cartilage 
experiences a traumatic knee injury, such as an ACL tear followed by ACLR (4, 22). Multiple 
studies and reviews have shown how kinematic and kinetic changes in the frontal (76, 77), 
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sagittal (78, 79), and transverse (77, 80) planes during walking gait occur early following ACLR 
(81) and persist for years (16). It is hypothesized these biomechanical alterations shift the load-
bearing contact locations of the joint to a new, previously unloaded, region of the cartilage (8, 
22). This shift to an area unconditioned to the new amount of loading initiates biological and 
compositional alterations in the cartilage that may result in structural changes and articular 
cartilage loss (8, 58).  
 Following ACLR, individuals commonly adopt a stiffened-knee gait strategy throughout 
stance phase, characterized by lesser peak knee flexion angle (KFA) and internal knee extension 
moment (KEM) (52, 82–84). Adoption of a stiffened-knee strategy is hypothesized to negatively 
influence force attenuation at the knee and contribute to the hastened development of PTOA (22, 
85). Lesser KFA and KEM may result in a smaller tibiofemoral contact area being loaded during 
gait (8, 19), which increases pressure on the knee joint if force remains constant and stimulates 
degenerative changes in the articular cartilage (86). Electromyography (EMG)-driven 
neuromuscular models have shown individuals with an ACLR demonstrate smaller total and 
medial tibiofemoral contact forces during different gait tasks (87), likely due to lower KEM and 
knee flexion excursion during gait (87). In uninjured participants, areas of tibiofemoral cartilage 
that undergo greater loading demonstrated thicker articular cartilage (20, 21), especially in 
medial tibiofemoral compartments (88). Additionally, individuals with an ACLR who 
demonstrated greater vertical ground reaction force (vGRF), vGRF loading rate, KFA, and KEM 
also demonstrated thicker medial femoral cartilage measured with US (26). Sufficient joint 
loading is necessary for optimal joint health; however, following ACLR, changes in kinetics and 
kinematics alter tibiofemoral contact forces as well as contact areas, potentially stimulating 
degenerative alterations in knee joint tissues. 
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B. Vertical Ground Reaction Force as a Marker of Biomechanical Loading  
 While many studies report kinetic and kinematic variables, fewer studies focus on vGRF, 
a variable that inherently influences kinetic measurements and contact force values. vGRF is a 
fundamental measure of load exerted during stance (23), and vGRF has been associated with 
joint tissue metabolism (9, 10), femoral cartilage morphology (26) and composition (17, 65), as 
well as PROs following ACLR (24, 25). Animal studies have found both excessive (89, 90) and 
insufficient joint loading (91) can lead to degenerative activity in the articular cartilage. 
Additionally, a recent study demonstrated that the association between higher vs. lower vGRF 
and PROs may alter based on the time from injury (24). Participants less than 1 year following 
ACLR who were symptomatic demonstrated lesser vGRF at both vGRF peaks and greater vGRF 
at mid stance compared to asymptomatic participants, while participants greater than 2 years 
following ACLR who were symptomatic demonstrated greater vGRF at both peaks and lesser 
vGRF at mid stance compared to asymptomatic participants (24). Greater vGRF associates with 
greater knee flexion excursion in both individuals with an ACLR (92) and individuals with 
radiographic KOA (93), and pilot data shows that increasing vGRF by 5% using biofeedback 
increases KFA in individuals with ACLR (94). Further pilot data shows that increasing vGRF 
using biofeedback results in less cartilage oligomeric matrix protein (COMP) effusion during 
walking compared to walking without biofeedback (40). vGRF is a fundamental measure of 
loading that is related to walking gait kinetic and kinematic variables as well as outcomes of 
KOA pathology and symptoms; therefore, it is an important variable to measure when evaluating 




C. Cumulative Loading and Physical Activity 
 Physical activity (PA) is important for overall health and maintenance of physical 
function following injury (95). Physical inactivity is independently responsible for 
approximately 6% of the disease burden from coronary heart disease, 7% from type 2 diabetes, 
10% from breast cancer, and 10% from colon cancer worldwide and causes 9% of premature 
mortality (96). One of the primary reasons for reduced participation in PA is musculoskeletal 
injury such as ACLR (67, 97). Evidence suggests individuals undergo less PA and daily steps 
following ACLR (11, 30). Individuals with ACLR participate in less objectively measured PA 
and take fewer daily steps compared to matched uninjured controls (11), and subjectively 
measured PA (measured with the Marx score) drops markedly from 2 to 6 to 10 years following 
ACLR (71). The Multicenter Orthopaedic Outcomes Network (MOON) Group also found that 
low Marx activity scores 2-years following ACLR is a significant predictor of knee pain 
(measured with KOOS pain scale) 6-years post-ACLR (30). PA may be a modifiable risk factor 
of PTOA onset; however, no study has associated objectively measured PA and outcomes of 
joint health following ACLR.  
 Amount of PA and daily steps are not only related to BMI and other measures of overall 
health (96), but also affect the amount of loading placed on the knee joint on a daily basis. 
Excessive loading (89) and underloading (91) are both detrimental to articular cartilage 
composition and structure, and studies measuring tibiofemoral cartilage thickness during gait 
suggest that regional cartilage thickness variations are influenced not only by the amount of 
loading per step, but also the number of loading cycles (88, 98). Measuring PA and daily steps is 
not only important to monitor overall health and risk of comorbidities following injury but is also 
important when evaluating the effect of loading on the knee joint following ACLR. 
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  The progression of KOA, specifically PTOA, is closely linked with aberrant 
biomechanical loading (5). However, most papers have evaluated walking gait kinematics and 
kinetics at a single time point (15, 16) which doesn’t reflect the total exposure to loading that 
occurs throughout a day, week or year. An individual could demonstrate a greater magnitude of 
force per step, but they could have a low step frequency per day. Similarly, an individual could 
demonstrate lesser magnitude of force per step but have a greater step frequency in a day. By 
accounting for step frequency in addition to magnitude, total exposure to biomechanical loading 
over time can be monitored and provide a more comprehensive evaluation of loading. Loading 
repetition is critical to understanding the interplay between mechanics and articular cartilage 
biology (5). Cumulative loading is an approach that utilizes the product of daily steps and an 
important walking gait biomechanical variable over a single step, such as vGRF (Equation 1).  
(1)   Cumulative Loading=daily steps x peak vGRF 
 
 This approach has been used to predict changes in OA in the lumbar spine (99) as well as 
to distinguish between healthy and osteoarthritic knees in a proof of concept study (14). Maly et 
al. (14) found cumulative knee adduction loading was better at discriminating between healthy 
and osteoarthritic groups compared to peak knee adduction moment (t51 = 3.97 vs. t59 = 2.84). As 
peak vGRF during walking gait associates with many variables of joint health and symptoms, 
cumulative vGRF load could help link the relationship between biomechanical loading, joint 




III. Early Measures to Evaluate Knee Joint Health 
 Articular cartilage outcomes can be broadly defined as markers of biology, morphology, 
composition, and structure. Changes in articular cartilage structure are generally only visible 
once irreversible cartilage loss has occurred (32), so newer more advanced outcome measures 
offer methods of detecting change in articular cartilage before permanent alterations have begun. 
Markers of biology include biochemical markers of inflammation (59), degenerative enzymatic 
activity (100), and type-II collagen metabolism (101). These biological changes can begin within 
24-hours of ACL injury (59). Changes in cartilage composition occur within one year following 
ACLR (63), and one of the most common composition outcomes is MRI T1rho relaxation time 
(34), indicative of proteoglycan content. Markers of morphology include ultrasound measures of 
cross-sectional area (CSA) (26), specifically change in CSA following a loading protocol (102). 
In vivo measurement of articular cartilage following a loading condition provides novel 
information regarding the relationship between loading condition magnitude and deformation of 
the cartilage (102). These measures together can provide a more complete picture of joint 
cartilage health, including outcomes of biology, composition, and morphology. 
 
A. Biochemical Markers of Cartilage Biology 
 Biochemical markers of type-II collagen and proteoglycan protein fragments as well as 
cytokines and degenerative enzymes can be measured from synovial fluid, serum and plasma. 
Biochemical markers can provide information about the metabolic and inflammatory 
environment of the articular cartilage (100). These markers can detect alterations in articular 
cartilage biology within one day following ACLR and provide valuable information regarding 
PTOA pathology prior to changes in composition or structure that are measured with imaging 
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modalities (100). Increases in inflammation (59, 103–106), degenerative enzymatic activity (107, 
108), and cartilage stabilizing proteins (105, 109) begin within 24-hours of initial ACL injury, 
while changes in type-II collagen begin within 4-weeks following ACLR (110). While 
interleukin-6 (IL-6) decreases in synovial fluid (SF) within 6-months, tumor necrosis factor 
alpha (TNF-a) remains higher for 5-years following ACL injury and ACLR (59). Matrix 
Metalloproteinases (MMP-3) (107, 108) and cartilage oligomeric matrix protein (COMP) (109) 
remain elevated for 1-year following ACLR, while there is conflicting evidence on how long 
alterations in type-II collagen degradation continues following ACLR (110, 111). Eight years 
post-ACLR, no biochemical markers in blood were elevated compared to uninjured controls 
(109, 112). Cross-sectional studies have shown that greater vGRF and vGRF loading rate 
associate with lesser type-II collagen turnover (9), inflammation (10), degenerative enzymatic 
turnover (10), and COMP release (40) in individuals post-ACLR. Based on the literature, IL-6, 
TNF-a, MMP-3, COMP, and C2C:CPII will be likely to associate with outcomes of joint health 






Table 1: Biochemical Markers of Inflammatory Cytokines  







10 uninjured, 60 ACL ruptures 
within 24 hours, 18 ACLR 
within 3-weeks, 8 ACLR 
within 3-14 months 
IL-6, TNF-a SF IL-6 and TNF-a increased immediately 
following ACLR and elevated at 3-
weeks and 3-months 
 
Neither were present in uninjured SF 
Struglics et 
al. 2015 




121 ACLR and ACLD 
participants and 21 uninjured 
controls, samples taken at 
baseline, 2 and 5 years 
 
Subset of 64 participants at 16, 
30, and 52 weeks after injury 
IL-6, TNF-a SF, 
serum 
SF IL-6 elevated at baseline but then 
returned to reference levels, SF TNF-a 
remained elevated from baseline to 5-
years post-ACLR compared to 
reference 
 







14 patients per-operatively, 1-, 
and 6-hours post-operatively  







 18 patients with ACLR pre-
operatively, at surgery, 3-days, 
2-, 5-, 12-, 18-, and 26-weeks 
post ACLR 
IL-6, TNF-a Plasma Levels did not change  
Ahlen et al. 
2015  
Cross-sectional 11 patients 8-years post-op 
(inter-limb comparisons) 
IL-6, TNF-a SF No difference between limbs, although 
radiographic changes were present 




cohort   
13 patients immediately pre-
op, 7-days post-op 
IL-6, TNF-a SF 
 
IL-6 higher post-op compared to pre-
op, TNF-a showed a trend towards 
lower post-op values 
Pietrosimone 
et al. 2017 
Cross sectional 
cohort 
18 ACLR patients. 
Biomarkers and walking 
biomechanics taken at a 6- and 
12-month follow-up 
IL-6 Plasma Greater IL-6 associated with 6-month 








Table 2: Biochemical Markers of Matrix Metalloproteinases (MMP-3) 
Author Study design Patient population Sample Results 
Lohmander et al. 1994, 
Lohmander et al. 1993 
Cross-sectional 
case-control 
 10 uninjured controls, 207 
participants at time of 
arthroscopy (some with other 
collateral ligament or meniscus 
tears) 
SF MMP-3 was elevated (25x) at time of 
injury to 6-months post-ACL injury 
compared to references, MMP3 still 
elevated (10x) 1-year following injury 
Dahlberg et al. 1994 Cross-sectional 
case-control  
10 uninjured controls, 207 
participants at time of 
arthroscopy (some with other 
collateral ligament or meniscus 
tears) 
SF MMP-3 elevated up to 6-months after 
ACL injury, MMP-3 6-months to 6-years 
after ACL injury matched reference levels 
Neuman et al. 2017 Prospective 
longitudinal 
case-control 
12 uninjured controls, 88 ACl 
injured individuals with 2-weeks 
of ACL injury and yearly for 7.5 
years  
SF MMP-3 was not different between those 
who developed KOA and those who did 
not 




18 ACLR patients. Biomarkers 
taken at initial presentation, 6- 
and 12-month follow-ups. 
Walking biomechanics taken at 
6- and 12-month follow-up 
Plasma Greater MMP-3 at initial presentation 
associated with lesser knee adduction 
moment limb symmetry index at the 6-
month exam, Greater MMP-3 at 6-months 
associated with lesser vGRF loading rate 
limb symmetry index and lesser knee 









Table 3: Biochemical Markers of Cartilage Oligomeric Protein (COMP) 
Author Study design Patient population Sample Results 




 18 patients with ACLR pre-
operatively, at surgery, 3-days, 
2-, 5-, 12-, 18-, and 26-weeks 
post ACLR 
Plasma Decreased 3-days post-op compared to 
pre-op, but then increased by 2-weeks 
post-op 
Ahlen et al. 2015  Cross-sectional cohort 11 patients 8-years post-op 
(inter-limb comparisons) 
SF No difference between limbs, although 
radiographic changes were present 





12 uninjured controls, 88 ACl 
injured individuals with 2-
weeks of ACL injury and 
yearly for 7.5 years  
SF 3x higher at 2-weeks post-injury 
compared to reference, returned to 
reference levels after 1-year 
Concentrations of COMP were not 
different between knee which had 
developed OA or not 
Luc-Harkey et al. 
2018 
Cross-sectional cohort 30 ACLR individuals (4±2 
years post-ACLR). Biomarkers 
taken pre and post walking 
biomechanics protocol 
Serum Greater COMP release after 20 minutes 








Table 4: Biochemical Markers of Type-II Collagen  
Author Study design Patient population Markers Sample Results 





45 individuals with ACL 
injury and 45 matched 
controls. Biomarker time 
points for ACL injured 
patients were 621±377 days 
prior to ACL injury and 
713±393 days from ACL 
injury to follow-up 
CPII, 
C2C 
Serum No difference in C2C:CPII between 
groups before injury, significant decreases 
in C2C over time in the ACL group 
compared to controls, CPII did not change 
in either group, C2C:CPII decreased over 
time in the ACL-injured group and 
increased in the control group 
Chmielewski 




28 uninjured controls and 28 
ACLR individuals, 
biomarker time points were 
4-, 8-, 12-, and 16-weeks 
post-ACLR 
CTX-II Urine Concentrations were higher in all ACLR 
time points compared to uninjured 
controls, CTX-II declined in ACLR 
patients over time  
Pietrosimone 
et al. 2016 
Cross-sectional 
cohort 
19 individuals 3±2.5 years 
post-ACLR; biomarkers and 
walking biomechanics 
collected 
C2C:CPII Serum Higher C2C:CPII associated with lower 
vGRF 
Pietrosimone 




18 ACLR patients at initial 
presentation, 6- and 12-
month follow-ups; 
biomarkers and walking 
biomechanics collected at 6- 
and 12-months post-ACLR 
C2C:CPII Serum  Higher C2C:CPII at initial presentation 
associated with lower vGRF limb 





B. Ultrasonographic Measures of Morphology 
 Cartilage morphology is commonly assessed with US as a single thickness measurement 
at various sections of the anterior femoral condyle (113). Recent studies (39) have shown that US 
can be utilized to measure changes in thickness and CSA following a loading protocol (38, 102, 
114). This change in deformation may provide insight into cartilage composition, as deformation 
may be a result of more water leaving the cartilage during loading, potentially due to depleted 
proteoglycan density (102). In uninjured controls, medial femoral cartilage CSA deforms by 
6.7% following a 5000-step loading protocol (102), however it is still unknown how cartilage 
deforms following walking in individuals with an ACLR. In a resting state, anterior femoral 
cartilage CSA is greater compared to the contralateral limb and uninjured controls (115). If CSA 
deformation is different in individuals with an ACLR compared to uninjured controls, it may be 
due to compositional changes following ACLR. Proteoglycan loss in the cartilage may associate 
with greater water content in the cartilage structure (34), which would result in greater CSA. 
Greater CSA may be due to cartilage swelling or hypertrophy following ACLR, and it is 
important to determine how anterior femoral cartilage reacts to biomechanical loading. 
 Some limitations exist with US as a measure of PTOA pathology. US can only capture 
the anterior portion of the femur and cannot capture the greatest weight-bearing region of the 
cartilage (38). One limitation in US studies is the researcher analyzing images has not been 
blinded to which images are pre- and post-loading (116). Lack of blinding may bias 
physiological changes demonstrated during walking. In the current study, researchers who are 




 all images from a participant together, in order to stay consistent with how the images are 
analyzed. Due to the novelty of utilizing US to measure femoral cartilage morphology, there are 
still several unknowns regarding analysis of US images.  
 Greater anterior femoral cartilage thickness measured with US in the involved limb of 
individuals with an ACLR associates with greater vGRF, KFA, knee flexion excursion and knee 
flexion impulse (26). While femoral cartilage measured with US associates with vGRF of a 
single step, it is unknown how physical activity and cumulative loading associate with US 
measured change in femoral cartilage CSA. US measured change in CSA in articular cartilage is 
likely to associate with loading in individuals 6- to 18-months following ACLR based on 







Table 5: Ultrasound Measures of Cartilage Morphology 












Cartilage thickness at 
medial condyle (MC), 
lateral condyle (LC) 
and intercondylar notch 
(IC) 
Larger vGRF, KFA, knee flexion excursion (KFE), 
and knee flexion impulse were associated with thicker 
MC cartilage. Larger KFE was associated with thicker 










walking, and running 
Percent change in 
medial femoral 
cartilage thickness  
30 minutes of walking and running resulted in 
cartilage deformation, but there was no difference in 
deformation between walking and running 
US medial femoral cartilage thickness was reliable 
















Significant medial thickness deformation occurred 
following walking and drop-landing, but was 











walking, and running 
Percent change in 
medial femoral 
cartilage thickness 
Slower walking speed associated with greater medial 
femoral cartilage deformation but not lateral or 
intercondylar notch 






20 ACLR individuals 
and 28 uninjured 
controls, resting US 
Femoral cartilage CSA 
and thickness (medial, 
lateral, intercondylar 
notch) 
ACLR limb presented with greater CSA and medial 
condyle thickness than the contralateral and uninjured 
control limbs, ACLR limb presented with greater 




C. Magnetic Resonance Imaging Markers of Cartilage Composition  
 T1rho MRI is sensitive to interactions between water and macromolecules, such as 
proteoglycans (34), and T1rho relaxation times have been found to correlate with depleted 
proteoglycan density in bovine (35) and human articular cartilage (36). Proteoglycan makes up 
about 40% of the dry weight of articular cartilage and is responsible for the high elasticity and 
resilience of the tissue (60). Loss of proteoglycan begins in the early stages of KOA and 
precedes type-II collagen loss (100). Decreased proteoglycan density of the articular cartilage is 
associated with early osteoarthritis progression (37), and decreased proteoglycans may be 
indicative of worse articular cartilage composition following injury. 
 T1rho relaxation time is elevated in articular cartilage of the involved limb compared to 
uninjured controls 1-year (36) and 2-years (64) following ACLR as well as compared to the 
contralateral limb 1-year (63) and 5-years (75) following ACLR. Evidence suggests T1rho 
relaxation times may increase over time on medial tibiofemoral cartilage and decrease over time 
on the lateral tibiofemoral cartilage 2-years following ACLR (64). T1rho values may be 
influenced by meniscal injury, as 1-year following ACLR, those without meniscal injury did not 
demonstrate elevated T1rho values while those with meniscal injuries demonstrated elevated 
T1rho values in the location of the meniscal injury (63). Lower KOOS scores associated with 
greater T1rho relaxation time 1-year following ACLR (74), and lower KOOS scores at 2-years 
associated with higher T1rho relaxation times in the involved limb 5-years following ACLR 
(75). Two studies have studied the relationship between walking biomechanics and T1rho values 
following ACLR, but results are contradictory. Pfeiffer et al. evaluated vGRF and MRI T1rho 
relaxation times as an inter-limb ratio, comparing the uninvolved limb to the contralateral limb’s 




T1rho relaxation times between limbs, and instead only measured T1rho relaxation times from 
the involved limb (65), which could contribute to the discrepancy between findings. It is still 
unknown if greater T1rho associates with greater or lesser loading following ACLR (17, 65). 
Based on this evidence, T1rho is likely to be a good marker of joint health that will correlate 







Table 6: Magnetic Resonance Imaging T1rho Relaxation Times 
Author Study design Participants T1rho measurements Results 
Li et al. 2011 Prospective 
longitudinal 
case-control  
12 ACLR at baseline 
and 1-year follow-up, 
10 age-matched 
uninjured controls 
Lateral femoral condyle 
(LFC), medial femoral 
condyle (MFC), lateral 
tibia (LT), medial tibia 
(MT), and patella  
MFC, LFC, MT, and LT 
all had 3 (tibia)-5 
(femur) 
subcompartments (1 is 
anterior, 5 is most 
posterior) 
T1rho of ACLR limb at baseline was 
elevated in LT3 compared to uninjured 
controls 
At 1-year T1rho in LT3 decreased compared 
to baseline but was still elevated compared 
with uninjured controls 
At 1-year, T1rho of ACLR limb in MFC2, 
MFC3, and MT2 were elevated compared to 
uninjured controls 





15 ACLR patients and 
16 uninjured controls 
scanned at baseline, 1- 
and 2-years post-
ACLR 
“” In ACLR limbs, T1rho increased on the 
medial side and decreased in the lateral side 
over 2-years 
Posterior LT values were significantly higher 
in ACLR limbs compared to uninjured 
controls at baseline and were not fully 
recovered at 1- or 2-years post-ACLR 
T1rho of MFC in ACLR limbs increased 







18 patients scanned 
12-16 months post-
ACLR 
“”  MT2 in the ACLR limb had greater T1ho 
compared to the contralateral knee, MFCs 1-
4 had greater T1rho as well as LFC2 and 
LFC5 
Patients without meniscal tears had no 
significant differences in T1rho compared to 
the contralateral knee, patients with medial 














25 young athletes post 
ACLR were followed 
for 5-years after return 
to sport clearance; 
KOOS scores collected 
at 2 years post- return 
to sport 
MRI collected 5-years 
post-return to sport. 
LFC, MFC, LT, and MT 
were each split into 3 
compartments (weight-
bearing regions only) 
Greater T1rho in ACLR limb in the 
superficial and deep layers of the anterior 
MFC and the superficial layers of the MT 
compared to contralateral limb 5-years post- 
return to sport 
Lower KOOS pain, symptoms, activities of 
daily living, and sport at 2-years post return 
to sport associated with greater T1rho in the 
ACLR limb compared to contralateral limb at 
5-years return to sport 
Pietrosimone 




18 individuals 1-year 
post-ACLR; KOOS 
collected at 1-year 
post-ACLR 
LFC, MFC, LT, and MT 
were each split into 3 
compartments (weight-
bearing regions only) 
Worse KOOS scores associated with greater 
T1rho in ACLR limbs normalized to 
contralateral limbs in posterior LFC (pain, 
ADL, sport, and QOL) and central LFC 
(sport and QOL) as well as anterior MFC 
(sport and QOL) 







MRI and walking 
biomechanics 
collected 6-months 
post-ACLR in the 
involved limb 
MRI in ACLR limb was 
normalized to 
contralateral limb. LFC, 
MFC, LT, and MT were 
each split into 3 
compartments (weight-
bearing regions only) 
Lesser peak vGRF associated with greater 
T1rho in anterior LFC, lesser KAM 
associated with greater T1rho in anterior LFC 
and posterior MTC 





33 ACLR individuals; 
Walking biomechanics 
at baseline, 6-, and 12-
months post ACLR. 
MRI taken at baseline, 
6-, 12-months, and 2-
years post-ACLR 
MFC, LFC, LFC, and LT Higher external knee flexion moment (KFM) 
and KFA before ACLR associated with 
greater increases in MFC T1rho 6-months 
post-ACLR. Higher KFM, KFA, and vGRF 
6-months post-ACLR associated with greater 






 PTOA is a condition affecting approximately 60% of individuals who experience an ACL 
tear or ACLR within 2 decades following initial injury. PTOA is a major contributor to global 
disability and affects a disproportionately high number of young individuals due to the young 
age associated with initial injury. PTOA development can be evaluated by its pathology or 
clinical symptoms, which do not always strongly correlate. Biomechanical loading of the joint is 
thought to influence cartilage biology and composition following traumatic knee injury, although 
amount and frequency of loading for optimal joint health is unknown. In order to evaluate the 
effects of a loading intervention, it is important to measure outcomes of pathology, such as 




CHAPTER 3: EXPERIMENTAL DESIGN AND METHODS 
Overview: Aims 1-3 
 The purposes of Aims 1-3 are to determine how habitual biomechanical loading, 
measured via daily steps, MVPA, and cumulative loading, influences PRO, outcomes of knee 
cartilage response to loading, and biomarkers of joint tissue metabolism and cartilage 
composition in individuals at least 6 months post-ACLR. The purpose of Aim 1 was to determine 
if individuals with an ACLR demonstrate an association between daily steps, MVPA, cumulative 
loading, and PRO. The purpose of Aim 2 was to determine if daily steps, MVPA, and cumulative 
loading associates with serum COMP response and cartilage CSA following a standardized 
walking protocol in individuals 6-18 months post-ACLR. The purpose of Aim 3 was to 
determine if daily steps, MVPA, and cumulative loading associated with biomarkers of joint 
tissue metabolism (serum MMP-3 and COMP) and cartilage composition (T1rho MRI relaxation 
times) in individuals 6-18 months post-ACLR. Alterations in biomechanical loading following 
ACLR influence PTOA development; however, no study has evaluated frequency of 
biomechanical loading influences PTOA outcomes following ACLR. The studies that are part of 
my dissertation seek to elucidate how frequency of biomechanical loading influences PRO and 




Participants: Aim 1 – Aim 3 
 For Aim 1, we included 66 participants who were at least 6 months removed from a 
primary unilateral ACLR. For our secondary and tertiary aims we included 36 participants who 
were 6-18 months following a primary unilateral ACLR. All participants were engaging in 
unrestricted physical activity as allowed by their orthopaedic physician. We excluded 
individuals: 1) with a history of musculoskeletal injury to either leg (e.g. ankle sprain, muscle 
strain) within 6 months prior to participation in the study, 2) a history of lower extremity surgery 
other than ACLR, 3) with a history of knee osteoarthritis or current symptoms related to knee 
osteoarthritis (e.g. pain, swelling, stiffness), 4) who were currently pregnant or planning to 
become pregnant while enrolled in the study, 5) with a history of cardiovascular restrictions that 
limited the participant’s ability to participate in physical activity. Participants were asked to self-
report age, sex, ACL graft type, and the date of ACL injury and ACLR. Height and weight were 
measured in the laboratory prior to testing.  
 
Experimental Procedures: Aims 1-3 
 This investigation utilized a cross-sectional study design. Participants in Aim 1 
completed one laboratory 
testing session where research 
assistants collected PRO and 
peak vGRF during walking 
gait biomechanics analysis. 

















accelerometer for 7 consecutive days immediately following the laboratory session, and daily 
steps and time in MVPA were analyzed from this data. Cumulative loading was calculated using 
peak vGRF and daily steps. Participants included in Aims 2-3 returned for a second laboratory 
testing session 17±12 days following the first session. During the second laboratory session, 
baseline biochemical markers of joint tissue metabolism and ultrasound measures of cartilage 
CSA were collected, following a 3000-step standardized treadmill walking protocol (Figure 1). 
Post-walking serum and cartilage CSA were collected immediately following cessation of the 
standardized walking protocol (Figure 1). For Aim 3, 26 consecutive participants also received 
an MRI at the Biomedical Research Imaging Center 27±22 days following the initial laboratory 
session.  The number of participants who received an MRI was dictated by our power analyses 
and funding.  
 
Collection of Daily Steps and Moderate to Vigorous Physical Activity 
 Immediately following the first testing session, participants were given an ActiGraph 
GT9X Link triaxial accelerometer. Participants were instructed to wear the accelerometer over 
the right anterior superior iliac spine for seven consecutive days immediately following the study 
visit for a valid data collection wear-period: a minimum of 4 days (3 weekdays and 1 weekend 
day) of wear with no less than 10 hours per day (117). Average daily steps and time spent in 
MVPA (minutes) were processed and analyzed using ActiLife software (v6.13.3). Freedson 
Adult VM3 cut points were used to categorize physical activity; Cut points >2690 counts/minute 
were considered MVPA. Daily steps were assessed using vertical acceleration data measured 
with the ActiGraph monitor. Variables were then normalized to the number of wear days to 






 Participant’s barefoot vGRF was collected at a self-selected walking speed over two 
Bertec force plates (40x60cm, FP406010, Bertec Corporation, Columbus, Ohio, United States) 
embedded in a 6-meter walkway so the entire stance phase for both the right and left limbs could 
be collected from a single trial (10, 11, 92). Participants were instructed to walk at a self-selected 
speed described as “comfortably walking over a sidewalk” and to look straight ahead 
maintaining a constant speed through two sets of infrared timing gates (TF100, Trac Tronix, 
Lenexa, Kansas) centered on the force plates. Once the participants felt comfortable with the 
task, five practice trials were performed to determine the average walking speed to be used 
during the test trials. During data collection participants performed five gait trials that were 
considered acceptable if: 1) Both right and left feet individually made contact with a single force 
plate for the entirety of stance; 2) A forward gaze was maintained; 3) Consistent gait speed 
(±5%) was maintained; 4) Gait was not visibly altered during the trial (i.e. no tripping or stutter 
stepping). Force data was sampled at 1200 Hz and low pass filtered at 10 Hz (4th order recursive 
Butterworth) (Pietrosimone et al., 2019). Stance was defined as the interval between heel strike 
(vGRF > 20 N) and toe off (vGRF < 20 N). Peak vGRF of each trial was extracted from the first 
50% of stance phase and then averaged across the five acceptable trials and normalized to body 
weight (BW). Cumulative loading was calculated as the product of daily steps and peak vGRF 
(Equation 1).  
(1)  𝐶𝑢𝑚𝑢𝑙𝑎𝑡𝑖𝑣𝑒 𝐿𝑜𝑎𝑑𝑖𝑛𝑔 =
(𝐷𝑎𝑖𝑙𝑦 𝑆𝑡𝑒𝑝𝑠)
2






Knee Injury and Osteoarthritis Outcomes Score (KOOS) 
 Participants completed all five subscales of the KOOS questionnaire (pain, symptoms, 
function in activities of daily living, function in sports and recreation, and knee related quality of 
life [KOOS QOL]) via a healthcare informatics system (REDCap, Vanderbilt University, 
Tennessee, USA). The KOOS questionnaire is a valid and reliable assessment of functional 
status and quality of life in individuals with ACLR. (28, 118). The KOOS was electronically 
scored to minimize processing error and each subscale was normalized to 100%, which was 
considered the best possible score for each subscale of the KOOS. Thereby higher scores 
indicated better PROs on all subscales.  
 We utilized a previous definition developed by Englund et al. (29) in an ACLR cohort to 
dichotomize participants into those with clinically significant knee related symptoms and those 
without clinically significant knee related symptoms. Individuals reporting KOOS QOL ≤ 87.5 
as well as two or more of the other 4 subscales below the cut-off values (KOOS Symptoms ≤ 
85.7; KOOS Pain ≤ 86.1; KOOS ADL ≤ 86.8, KOOS Sports ≤85.0) were considered to 
demonstrate clinically significant knee related symptoms (29). For the current study, we 
considered individuals with clinically relevant knee related symptoms as symptomatic and 
individuals without clinically relevant knee related symptoms as asymptomatic. Approximately, 
43% (N=1530) and 39% (N=1506) of the individuals enrolled in the Multicenter Orthopeadic 
Outcomes Network (MOON) Knee Project cohort were symptomatic using the same criteria at 2 








Upon arrival to the laboratory, participants rested on a treatment table with their knees in 
full extension for 45 minutes to unload the cartilage and minimize effects of preceding activity 
on the cartilage (119). After 45 minutes, participants were positioned supine with their knees 
flexed to140° which was confirmed using a manual goniometer (Figure 2). The head of each 
subject was positioned at the top of the table. A tape measure was secured to the top of the table 
and used to ensure that the head, hip and heel of the foot were aligned at the same point on the 
table before and after the standardized walking protocol (Figure 2). A LOGIQe US system 
(General Electric Co., Fairfield, CT) with a 12 MHz linear probe was used to take 3 images of 
the anterior portion of the femoral articular cartilage. The probe was placed transversely in line 
with the medial and lateral femoral condyles above the superior edge of the patella and rotated to 
maximize reflection of the articular cartilage surface (38, 119). Measures on the involved limb 
were taken immediately before (CSAPRE) and immediately following (CSAPOST) the standardized 
walking protocol. CSAPOST images were captured within 5 minutes following cessation of 
treadmill walking.  
 
Ultrasound image analysis 
 Ultrasound images were processed using ImageJ software (National Institutes of Health, 
Bethesda, MD). The femoral cartilage was segmented by individually determining the entire 
visualized cartilage–bone interface and soft tissue–cartilage interface for the cartilage of the 
femur to obtain the cartilage CSA (mm2, Figure 3). CSA from each of the 3 images were 
averaged to create a mean CSAPRE and a CSAPOST value. A percent change score from baseline to 




the standardized loading protocol (%ΔCSA). A greater negative percentage change in CSA 
indicated greater cartilage deformation and more positive percent change indicated greater 
cartilage swelling (Equation 2). 
(2)   %𝛥𝐶𝑆𝐴 =
𝐶𝑆𝐴𝑝𝑜𝑠𝑡−𝐶𝑆𝐴𝑝𝑟𝑒
𝐶𝑆𝐴𝑝𝑟𝑒
∗ 100   
 
Serum Collection and Analysis of Cartilage Oligomeric Matrix Protein (COMP) 
 Five milliliters of antecubital venous blood were collected via a standard vacutainer 
serum collection tube with a 21-gauge needle both immediately before and immediately 
following the standardized walking protocol. Serum tubes were placed on ice until centrifuged at 
4 °C for 10 min at 3000g (120). Serum was pipetted equally into two 1.5 mL cryovials and 
stored in a −80 °C freezer for batch analysis following completion of the study. Serum COMP 
concentration was assessed via a commercially available specific enzyme-linked immunosorbent 
assay (ELISA) (BosterBio, Pleasanton, CA) with an assay detection sensitivity of<10 pg/mL. For 
all assays, unknown samples were diluted 100x and all standards, samples, and controls were 
performed in duplicate determinations. All assays demonstrated an average intra-assay 
variability of 2.8%, and all assays demonstrated an intra-assay variability <10.6%. We calculated 
percent change scores in COMP following the loading session to determine %∆COMP (Equation 
3).  
(3)    %𝛥𝐶𝑂𝑀𝑃 =
𝐶𝑂𝑀𝑃𝑝𝑜𝑠𝑡−𝐶𝑂𝑀𝑃𝑝𝑟𝑒
𝐶𝑂𝑀𝑃𝑝𝑟𝑒
 𝑥 100               
 
Treadmill Walking Protocol 
 The standardized walking protocol was adapted based on similar walking protocols 




and speed was increased at 0.5 m/s up to their preferred walking speed determined during the 
vGRF assessment. Participants walked at this speed for 3,000 steps. Once the participant reached 
3,000 steps, the treadmill was slowed at 0.5 m/s to a stop. The plinth was placed approximately 
2m away from the treadmill to minimize steps taken between the treadmill and plinth. Overall, 
an average of 3017±14 steps were taken, including moving onto and off the treadmill to the 
plinth. Once the participant reached the plinth, they repositioned their knees to 140° of flexion, 
and CSAPOST was measured.  
 
Serum Matrix Metalloproteinase-3 (MMP-3) and Cartilage Oligomeric Matrix Protein (COMP) 
Analysis  
 
 Five milliliters of blood were collected via syringe from the antecubital fossa with a 21-
gauge needle. Blood was immediately transferred to a serum separation tube vacutainer. After 
clotting, tubes were placed on ice until centrifuged at 4°C for 10 minutes at 3000 rpm. Serum 
was pipetted equally into four 2.0-mL cryovials and stored in an –80°C freezer for batch analysis 
at the end of the study. Serum was assessed for MMP-3 and COMP via a commercially available 
specific enzyme-linked immunosorbent assay (ELISA; R&D Systems, Minneapolis, MN). 
Specific assay detection sensitivity for MMP-3 was 0.009 ng/mL, and sensitivity for COMP was 
<10 ng/mL. All standards, controls, and samples were performed in duplicate determinations and 
demonstrated intra-assay variability <10%. The average variability of MMP-3 was 1.3±1.2%, 
and the average variability of COMP was 2.9±2.3%.  
 
Magnetic Resonance Image Acquisition 
 T1rho MRI were acquired on the ACLR limb followed by the uninjured contralateral 




mm x 224 mm, Siemens, Munich, Germany). Upon arrival to the biomedical imaging center, 
participants remained seated for 45 minutes to unload the knee cartilage (102). We used a T1rho 
prepared three-dimensional Fast Low Angle Shot (FLASH) with a spin-lock power at 500Hz, 
five different spin-lock durations (40, 30, 20, 10, 0 ms) and a voxel size of 0.8mm x 0.4mm x 
3mm (field of view= 288mm, slice thickness=3.0mm, 160 × 320 matrix, gap= 0mm, flip 
angle=10°, echo-train duration time= 443ms, phase encode direction of anterior/posterior) (121). 
Before segmentation, an affine registration technique was used to register the ACLR limb image 
to the uninjured limb image using the 3-D Slicer software (122). After the affine registration, a 
nonrigid deformable, voxel-by-voxel intensity-based registration technique was applied to 
account for specific interlimb differences of specific tissues (e.g., bone and cartilage), which 
would ensure a more accurate alignment of the ACLR limb to the uninjured limb. 
 
Segmentation of the Articular Cartilage 
 The articular cartilage in the medial and lateral condyles of the femur was manually 
segmented using ITK-SNAP software (123) on a T1rho MRI acquired during the 0 ms spin-lock 
duration.  Manual segmentation of the articular cartilage has demonstrated strong reliability in 
our laboratory for all regions of interest (ROI) (intra-rater reliability, N=8, ICC = 0.80-0.97; 
inter-segmentor reliability, N=10, ICC = 0.75-0.98) (74). The medial and lateral femoral (MFC 
and LFC) were further sub-sectioned into three regions of interest (ROIs), based upon the 
location of the meniscus in the sagittal plane (74). The three ROI that were sub-sectioned 
represent load-bearing regions of the femoral condyle and included: 1) the cartilage overlying the 




lies between the anterior and posterior horns of the meniscus (Central MFC/LFC); and 3) the 
cartilage corresponding with the anterior horn of the meniscus (Anterior MFC/LFC) (121).  
 
T1rho MRI Relaxation Time Quantification  
 Voxel by voxel T1rho relaxation maps were constructed from a five-image sequence 
using a MatLab program (MatLab R2014b [8.4.0] MathWorks, Natick, MA, USA) with the 
following equation: S(TSL) = S0 exp(-TSL/T1rho). In this equation TSL is the duration of the 
spin-lock time, S0 is signal intensity when TSL equals zero, S corresponds to signal intensity, 
and T1rho is the T1 relaxation time in the rotating frame. The previous segmentation image was 
transposed over the T1rho image to establish T1rho MRI relaxation times for each ROI (121). A 
mean of the T1rho MRI relaxation times for each ROI was calculated using the ITK-SNAP 
software (123). Higher T1rho MRI relaxation times are interpreted as tissue consisting of lower 
proteoglycan density (63). We calculated T1rho MRI as an interlimb ratio determined as the 
T1rho MRI relaxation time for the ROI of the ACLR limb normalized to the same ROI in the 
uninjured contralateral limb (T1rho interlimb ratio= ACLR limb/uninjured limb), as described 
previously (17, 121). T1rho MRI interlimb ratio with a value greater than 1.00 can be interpreted 
as demonstrating greater T1rho MRI relaxation times on the ACLR limb as compared with the 
uninjured contralateral limb, indicative of lower proteoglycan density in the ACLR limb. 
 
Sample Size Analysis 
Aim 1 
 We estimated the association between daily steps, MVPA, and cumulative loading based 




and KOOS in an ACLR cohort. Additionally, we included covariates (time from ACLR and 
walking speed) in our predictions, as time from ACLR correlates with KOOS (71). We 
determined that at least 63 individuals were needed in order to detect statistical significance 
using a multiple linear regression analysis if R2 = 0.17 (alpha level set at 0.05 and 80% power; 
G*Power, v3.1.9.2) (124). We recruited 66 participants to account for the removal of data points 
that may be considered statistical outliers. We estimated the 66 participants from our primary 
aim would allow us to find a moderate association (R2 = 0.25) between daily steps, MVPA, 
cumulative loading and KOOS scores within asymptomatic and symptomatic groups following 
ACLR for our secondary aim.  
 
Aim 2 
 We estimated a moderate association would be detected between daily steps, MVPA, and 
cumulative loading with %ΔCOMP and %ΔCSA based on previous data (40) which found a 
significant association (R2 = 0.208, P = 0.019) between biomechanical loading (vGRF) and 
%ΔCOMP following a treadmill walking protocol. Therefore, we estimated 34 individuals were 
needed in order to detect a statistically significant association with an R2 = 0.208 and an alpha 
level of 0.05 and 80% power (G*Power, v3.1.9.2) (Faul et al., 2007). We recruited an additional 
2 participants (N=36) to maintain statistical power in the event outliers were removed from the 
final dataset or data points were missing due to the inability to obtain blood samples.  
 
Aim 3 
 We estimated a moderate association would be detected between daily steps, MVPA, 




association (R2 = 0.29) between knee adduction moment, a measurement of biomechanical 
loading, and MMP-3 in individuals with an ACLR (10). Age was included as a covariate because 
age associates with several joint tissue metabolism biomarkers (33, 100). Therefore, 35 
participants were needed in order to detect statistical significance for a linear multiple regression 
with an R2 of this magnitude with an alpha level set at 0.05 and 80% power with 1 covariate 
(G*Power, v3.1.9.2) (124). We recruited an additional participant (N=36) to maintain statistical 
power in the event an outlier was removed from the final dataset or a data point was missing due 
to the inability to obtain blood samples. We also estimated a moderate association would be 
detected between daily steps, MVPA, and cumulative loading and T1rho MRI relaxation time in 
the femoral cartilage based on previous data evaluating the association  significant association 
(R2 = 0.37) between daily steps and change in T1rho MRI relaxation times of the medial tibial 
condyle following a day of normal physical activity in uninjured healthy individuals (125). 
Therefore, we needed 26 participants in order to detect statistical significance for a linear 
multiple regression with an R2 of this magnitude with an alpha level set at 0.05 and 80% power 
(G*Power, v3.1.9.2) (124). We collected T1rho MRI on 26 consecutive participants who 
participated in the study until the sample size was reached. 
 
Statistical Analysis 
 Prior to primary analysis, outliers were determined via box plots as any data point greater 
than 3 standard deviations from the mean. Independent t-tests were conducted to determine 
differences between asymptomatic vs symptomatic groups for Aim 1, and males vs. females for 




variances were conducted to determine differences between asymptomatic males, symptomatic 
males, asymptomatic females, and symptomatic females in Aim 1. 
 
Aim 1 - Association between KOOS and daily steps, MVPA, and cumulative loading 
 For our primary analyses, we conducted separate univariate linear regression analyses 
with each physical activity or cumulative loading variable (daily steps, MVPA, cumulative 
loading) as separate dependent variables and each KOOS subscale as separate independent 
variables. Age associates with physical activity (126), time from ACLR associates with the 
KOOS (71) and walking speed associates with vGRF (10). Therefore, age and time from ACLR 
were included as covariates in each linear regression equation for daily steps and MVPA prior to 
adding the KOOS variable of interest. For regressions with cumulative loading as a dependent 
variable, we included age, time from ACLR and preferred walking speed as covariates prior to 
adding the KOOS variable of interest. We evaluated the change in R2 (∆R2) in the dependent 
variable (daily steps, MVPA, or cumulative loading) from each separate independent variable 
(each KOOS subscale) after accounting for variance from both covariates. For our secondary 
analyses, separate univariate linear regressions were conducted between each physical activity or 
cumulative loading variable and KOOS subscales as described for the primary aim within each 
group (asymptomatic and symptomatic).  
 
Post Hoc Analyses  
 Recent evidence suggests female participants with an ACLR, but not male participants 
with an ACLR are less physically active compared to uninjured controls (127).  Therefore, the 




symptomatic males, and asymptomatic males. We then conducted separate post-hoc univariate 
linear regression analyses with each physical activity or cumulative loading variable (daily steps, 
MVPA, cumulative loading) as separate dependent variables and each KOOS subscale as 
separate independent variables. Age, time from ACLR, and walking speed were not included as 
covariates in this analysis due to not overfit our linear regression models. We evaluated the 
change in R2 (∆R2) in the dependent variable (daily steps, MVPA, or cumulative loading) from 
each separate independent variable (each KOOS subscale) after accounting for variance from the 
covariates. The level of significance for all analyses was determined a priori at P<0.05 and all 
analyses were performed using the Statistical Package for the Social Sciences software (SPSS, 
Version 21.0, IBM Corp., Somers, NY).  
 
Aim 2 – Association Between Daily Steps, MVPA, Cumulative Loading, and %ΔCOMP  and 
%ΔCSA 
 
 For the primary analyses, separate stepwise univariate linear regression models were 
constructed to determine the unique associations between habitual biomechanical loading 
variables (daily steps, MVPA, and cumulative loading) and measures of knee cartilage response 
to loading (%∆CSA and %∆COMP). Separate regression equations were constructed using 
%∆CSA and %∆COMP as dependent variables and daily steps, MVPA, and cumulative loading 
were individually evaluated as independent variables in separate equations. Walking speed was 
added to each regression equation prior to the independent variable of interest. We evaluated the 
change in R2 (∆R2) and unstandardized beta (β) in the dependent variable (%∆COMP or 
%∆CSA) from each independent variable (daily steps, MVPA, or cumulative loading) after 
accounting for the variance from walking speed. Sex has been shown to influence biochemical 




cohort was stratified by sex, and univariate linear regression analyses were analyzed similarly 
between independent (daily steps, MVPA, and cumulative loading) and dependent variables 
(%∆CSA and %∆COMP) with walking speed as a covariate. Similarly, ∆R2 and β in the 
dependent variable were evaluated after accounting for walking speed.  
 
Post-hoc Analyses 
 Results from the primary analysis revealed not all participants decreased CSA following 
the walking protocol. Based on previously calculated (102) minimal detectable change following 
a standardized walking protocol (MDC, ≥ 3.82 mm2) we stratified the entire cohort based on the 
magnitude of change in CSA (CSAPOST - CSAPRE) observed following our standardized walking 
protocol. Participants who demonstrated a decrease in CSA of at least 3.82 mm2 were defined as 
deformers, while those who did not deform by at least 3.82 mm2 were classified as non-
deformers. We then conducted post-hoc analyses utilizing two-tailed independent t-tests to 
determine if there were differences in daily steps, MVPA, or cumulative loading between 
deformers and non-deformers. Statistical significance was determined a priori as P ≤ 0.05, and 
all statistical analyses were performed using the Statistical Package for the Social Sciences 
software (SPSS, Version 21, IBM Corp., Somers, NY). 
 
Aim 3 – Association Between Daily Steps, MVPA, Cumulative Loading, and MMP-3, COMP, 
and T1rho MRI relaxation time 
 
 For the primary analyses, separate stepwise univariate linear regression models were 
constructed to determine the unique associations between habitual biomechanical loading 
variables (daily steps, MVPA, and cumulative loading) and measures of knee joint tissue 




ratios). Separate regression equations were constructed using MMP-3, COMP, and T1rho MRI 
interlimb ratio as dependent variables and daily steps, MVPA, and cumulative loading were 
individually evaluated as independent variables in separate equations. Age was included as a 
covariate in all linear regressions where MMP-3 or COMP were the dependent variable 
(Lohmander, Roos, Dahlberg, Hoerrner, & Lark, 1994), as age associates with biochemical 
markers of joint tissue metabolism. Age was added to each regression equation prior to the 
independent variable of interest. We evaluated the change in R2 (∆R2) and unstandardized beta 
(β) in the dependent variable (MMP-3 or T1rho MRI interlimb ratios) from each independent 
variable (daily steps, MVPA, or cumulative loading) after accounting for age.  
 
Post Hoc Analysis  
 Sex has been shown to influence biochemical markers of joint tissue metabolism 
following ACLR (41, 42). Therefore, as a post hoc analysis, the cohort was stratified by sex, and 
separate regression equations were constructed using MMP-3, COMP, and T1rho MRI interlimb 
ratios as dependent variables and daily steps, MVPA, and cumulative loading were individually 
evaluated as independent variables in separate equations. Age was not included as a covariate in 
the secondary analysis due to small sample size once stratified by sex. We evaluated ∆R2 and β 
in the dependent variable from each independent variable. Statistical significance was 
determined a priori as P ≤ 0.05, and all statistical analyses were performed using the Statistical 




CHAPTER 4: RESULTS 
Specific Aim 1 
 The primary aim is to determine the association between daily steps, time spent in 
moderate to vigorous physical activity (MVPA), cumulative loading (Cumulative loading = daily 
steps x peak vGRF), and patient-reported outcomes (PROs) in individuals post-ACLR. The 
secondary aim is to separately determine these associations within asymptomatic and 
symptomatic individuals post-ACLR.  
 
Results Aim 1 
 Sixty-six individuals completed all aspects of the current study. Thirty-six individuals 
were asymptomatic, and 30 individuals were symptomatic based on KOOS subscales. The 
symptomatic group demonstrated significantly lower KOOS subscale scores compared to the 
asymptomatic group, as expected. The symptomatic group demonstrated less time from ACLR 
compared to the asymptomatic group (t65 = 2.22, p = 0.031). There were no significant 
differences between groups for any dependent variables (daily steps, MVPA, cumulative 
loading), demographic variables, or walking speed.  
 
Primary Analyses – Associations Within Entire Cohort 
 No significant associations were identified between dependent variables (daily steps, 
MVPA, and cumulative loading) and independent variables (KOOS subscales) (range ∆R2 = 




Secondary Analyses – Associations Within Symptomatic and Asymptomatic Individuals  
 Greater time in MVPA associated with higher KOOS QOL (∆R2 = 0.150, B = 0.701, p = 
0.038) in symptomatic individuals but not in asymptomatic individuals (∆R2 = 0.05, β = -0.188, 
p = 0.679). No other significant associations were identified between dependent variables (daily 
steps, MVPA, and cumulative loading) and independent variables (KOOS subscales) in either the 
asymptomatic group (range ∆R2 = 0.001 – 0.023, p > 0.05) or the symptomatic group (range ∆R2 
= < 0.001 – 0.144, p > 0.05). 
 
Post-Hoc Analyses – Associations Within Asymptomatic Males, Symptomatic Males, 
Asymptomatic Females, and Symptomatic Females 
 
 Greater MVPA associated with higher KOOS QOL in symptomatic females (R2 = 0.230, 
B = 0.916, P = 0.038, Figure 2, Table 4) but not in symptomatic males (R2 = 0.196, P > 0.05, 
Table 4), asymptomatic males (R2=0.045, P>0.05, Table 4),or asymptomatic females (R2 =0.008, 
P > 0.05, Table 4). Greater MVPA also associated with higher KOOS sport in symptomatic 
males (R2 = 0.470, β=1.171, P=0.020, Figure 3, Table 4). Daily steps (R2 < 0.001 – 0.210, P > 
0.05, Table 4) and cumulative loading (R2 < 0.001 – 0.285, P > 0.05, Table 4) did not associate 
with any KOOS subscales in symptomatic females, symptomatic males, asymptomatic males or 
asymptomatic females.  
 
Specific Aim 2 
 Determine the association between daily steps, MVPA, cumulative loading, and cartilage 
deformation and change in serum COMP following a standardized loading protocol in 





Results Aim 2 
 After accounting for walking speed, daily steps, MVPA, and cumulative loading did not 
significantly associate with %∆COMP in individuals post-ACLR (ΔR2 range: 0.068 – 0.088, 
P>0.05, Table 2). Similarly, daily steps, MVPA, and cumulative loading did not significantly 
associate with %∆CSA (ΔR2 range: 0.002 – 0.041, P>0.05, Table 2).  
 
Secondary Analysis: Associations in Males and Females 
 Males who engaged in greater daily steps (ΔR2=0.382, β=-0.005, P=0.013, Table 3 
Figure 4), greater time in MVPA (ΔR2=0., β=-0.452, P=0.040, Table 3 Figure 5), and greater 
cumulative loading (ΔR2=0.421, β=-0.009, P=0.008, Table 3 Figure 6) demonstrated lesser 
%∆COMP. Daily steps, MVPA, and cumulative loading did not significantly associate with 
%∆COMP in females (ΔR2 range: <0.001 – 0.015, P>0.05, Table 3) and did not associate with 
%∆CSA in males (ΔR2 range: 0.034 – 0.057, P>0.05, Table 3) or females (ΔR2 range: 0.018 – 
0.036, P>0.05, Table 3). 
 
Post Hoc Analysis: Differences in habitual biomechanical loading between deformers and non-
deformers 
 
 Seven participants were classified as deformers (CSAPOST-CSAPRE= -7.40 mm
2) while 29 
participants were classified as non-deformers (CSAPOST-CSAPRE= -7.40 mm
2) based on 
demonstrating a decrease in CSA of at least 3.82 mm2. There was no significant difference in 
daily steps (non-deformers=8043±2325 steps, deformers = 6697±1588 steps, t34=1.44, p=0.158), 
MVPA (non-deformers=62±24 minutes/day, deformers=56±19 minutes/day, t34=0.61, p=0.543), 
or cumulative loading (non-deformers=4439±1379 BW/day, deformers=3608±1004 BW/day, 




Specific Aim 3 
 Determine the association between daily steps, MVPA, and cumulative loading and 
biomarkers of joint tissue metabolism and T1rho MRI measures of cartilage composition in 
individuals between 6-18 months following ACLR. Daily steps, MVPA, and cumulative loading 
will be collected as described in Aim 1. 
 
Results Aim 3 
 Greater concentrations of MMP-3 associated with greater minutes spent in MVPA 
(∆R2=0.152, β=0.135, P=0.015, Table 3, Figure 1). Greater T1rho MRI interlimb ratios for the 
central LFC ROI associated with greater MVPA (∆R2=0.178, β=0.002, P=0.032, Table 3, Figure 
2). No significant associations existed between MMP-3 and daily steps (∆R2=0.01, β<0.001, 
P=0.549, Table 3) or cumulative loading (∆R2=0.029, β=0.001, P=0.305, Table 3). No 
significant associations existed between MVPA and T1rho MRI interlimb ratios for all other 
ROIs (∆R2 range < 0.001 – 0.118, P>0.05, Table 3). No significant associations existed between 
T1rho MRI interlimb ratios and daily steps (∆R2 range < 0.001 – 0.071, P>0.05, Table 3) or 
cumulative loading (∆R2 range < 0.001 – 0.072, P>0.05, Table 3). No significant associations 
existed between COMP and daily steps, MVPA, or cumulative loading (R2 range = 0.001 – 
0.024, P>0.005, Table 3). 
 
Post Hoc Analysis – Associations in Males and Females 
Male Subgroup 
 Males did not demonstrate significant associations between MMP-3 and daily steps, 




associated with greater T1rho MRI interlimb ratios in the posterior MFC (R2=0.574, β<0.001, 
P=0.011, Table 3), central MCF (R2=0.639, β<0.001, P=0.006, Table 3), and anterior MFC 
(R2=0.661, β<0.001, P=0.004, Table 3) T1rho MRI interlimb ratios in males. Greater MVPA 
associated with greater anterior LFC (R2=0.497, β=0.002, P=0.023, Table 3), posterior MFC 
(R2=0.450, β=0.002, P=0.034, Table 3), central MFC (R2=0.713, β=0.003, P=0.002, Table 3), 
and anterior MFC (R2=0.753, β=0.003, P=0.001, Table 3) T1rho MRI interlimb ratios in males. 
Greater cumulative loading associated with greater posterior MFC (R2=0.619, β< -0.001, 
P=0.007, Table 3), central MFC (R2=0.706, β< 0.001, P=0.002, Table 3), and anterior MFC 
(R2=0.651, β< 0.001, P=0.005, Table 3) T1rho MRI interlimb ratios in males. COMP did not 
associate with daily steps, MVPA, or cumulative loading in males (R2 range = 0.002 – 0.059, 
P>0.05, Table 3). 
 
Female Subgroup 
 Fewer daily steps associated with greater posterior MFC (R2=0.304, β< -0.001, P=0.027, 
Table 3) and central MFC (R2=0.276, β< -0.001, P=0.037, Table 3) T1rho MRI interlimb ratios 
in females. There was no association between T1rho MRI interlimb ratios and MVPA in females 
(R2 range = <0.001 – 0.120, P>0.05, Table 3). Lesser cumulative loading associated with greater 
posterior MFC (R2=0.309, β= < -0.001, P=0.025, Table 3) and central MFC (R2=0.292, β< -
0.001, P=0.031, Table 3) interlimb ratios in females. Females did not demonstrate significant 
associations between MMP-3 and daily steps, MVPA, or cumulative loading (R2= <0.001 – 
0.027, P>0.05, Table 3). All other T1hrho interlimb ratios did not associate with daily steps, 




COMP did not associate with daily steps, MVPA, or cumulative loading in females (R2 range = 





CHAPTER 5: MANUSCRIPTS 
Manuscript 1 
Higher Quality of Life Associates with Greater Moderate and Vigorous Physical Activity in 




Between 43% (129) and 63% (130) of patients report not returning to pre-injury levels of 
physical activity following ACLR.  Approximately 43% and 39% of individuals report persistent 
clinically relevant knee symptoms measured with the Knee Injury and Osteoarthritis Outcomes 
Score (KOOS) at 2 and 6 years following ACLR, respectively (30). Furthermore, longitudinal 
cohort studies demonstrate that improvements in patient-reported outcomes (PRO) remain 
relatively stagnant between 2 and 10 years post-ACLR, with individuals reporting significantly 
impaired function compared to uninjured controls throughout the first decade post-ACLR (71). It 
is critical to determine the factors associated with persistent deficits in PRO in order to develop 
novel interventions needed to improve long-term PROs following ACLR.  
Aberrant walking gait biomechanics measured during a single step have been linked to 
worse PRO following ACLR (24, 25). Worse PROs at 12 months post-ACLR are associated with 
lesser peak vertical ground reaction force (vGRF) in the first 50% of stance 6 months post-
ACLR (25). Other studies have dichotomized individuals into those who demonstrate clinically 
relevant symptoms (symptomatic) and those who do not demonstrate clinically relevant 
symptoms (asymptomatic) (29), and symptomatic individuals demonstrate lesser vGRF in 




vGRF is also associated with deleterious changes in joint tissue metabolism (10) and altered 
cartilage composition within the first 6 months following ACLR (17), which may be related to 
long-term health of the joint. Therefore, lesser peak vGRF may be indicative of early PTOA 
development, which may be an underlying mechanism linking early underloading to worse PRO. 
While there is evidence that peak vGRF during a single step is an important biomechanical 
indicator linked to PRO following ACLR, peak vGRF does not provide information regarding 
the total exposure to biomechanical loading experienced during habitual daily loading. 
Greater participation in physical activity associates with better health related quality of 
life in healthy children (131), chronically ill children (132), and older adults (132); however no 
study has evaluated physical activity and quality of life in individuals with ACLR. In a previous 
cross-sectional study, individuals 6-67 months post-ACLR engaged in fewer daily steps and less 
time in moderate or vigorous physical activity (MVPA) measured with hip-mounted 
accelerometers compared to uninjured controls (11). Daily step counts and time spent in MVPA 
can provide estimates of the frequency of lower extremity loading (14, 133), and engaging in 
fewer daily steps and less time in MVPA may reduce frequency and intensity of loading, 
respectively. Additionally, cumulative loading, measured as the product of daily steps and peak 
vGRF, may be utilized to measure total exposure to daily lower-extremity loading (14, 18). 
Cumulative loading measured as the product of knee adduction moment and daily steps has been 
utilized to distinguish uninjured controls and individuals with knee osteoarthritis (KOA) (14). 
Additionally, both excessive and insufficient amounts of cumulative loading measured with body 
mass index (BMI) and daily steps associate with cartilage damage in individuals with KOA 
(133). In the current study we will utilize peak vGRF and daily steps to calculate cumulative 




metabolism (9, 10), and cartilage composition (17, 65) post-ACLR. Cumulative loading may be 
critical to determine optimal joint loading necessary to mitigate PTOA symptoms following 
ACLR. Additionally, engaging in less time in MVPA has negative implications for long-term 
health including increased adiposity (134), decreased health-related quality of life (135), and 
increased risk of chronic diseases (135). Evaluating the associations between different outcomes 
of habitual biomechanical loading (i.e. daily steps, MVPA, and cumulative loading) and PRO is 
an important step in determining optimal biomechanical loading following ACLR.  
Therefore, the primary purpose of the current study was to determine the association 
between daily steps, MVPA, cumulative loading, and PROs in individuals post-ACLR. We 
hypothesized that there would be a positive association between greater daily steps, time in 
MVPA, and cumulative loading and worse KOOS outcomes. Walking gait biomechanics are 
different between symptomatic individuals and asymptomatic individuals based on PROs (24). 
Therefore, the secondary purpose was to determine the associations between outcomes of 
habitual biomechanical loading (daily steps, MVPA, and cumulative loading) and PROs 
separately in symptomatic and asymptomatic groups (24, 29).  We hypothesized that 
symptomatic individuals would demonstrate the strongest positive associations between daily 




 Data were collected from individuals with unilateral ACLR enrolled in two separate 
cross-sectional studies. All main outcomes were assessed during a single testing session. 




Daily steps and MVPA were assessed using an ActiGraph GT9X Link triaxial accelerometer 
worn for seven consecutive days following the initial testing session. The Institutional Review 
Board at our institution approved all methods, and all participants provided written informed 
consent prior to participation. 
 
Participants and Power Analysis 
 Individuals were included if they had undergone unilateral ACLR prior to data collection, 
had physician approval to return to unrestricted participation in physical activity, were between 
the ages of 18-35 years, and had a BMI ≤ 35 kg/m2. BMI was restricted to ≤35 kg/m2 because 
this criteria was used in the larger clinical trial that the current study leveraged. Individuals were 
excluded if they were currently pregnant, had been previously diagnosed with any form of 
inflammatory arthritis, needed a multi-ligament reconstruction, or had a previous history of 
ACLR on the involved or contralateral limb. Demographic data are provided in Table 1. We 
estimated a weak association between daily steps, MVPA, and cumulative loading based on 
previous data (25), which found a weak but significant association (R2 = 0.17) between vGRF 
and KOOS in an ACLR cohort. Additionally, we included covariates (time from ACLR and 
walking speed) in our predictions, as time from ACLR correlates with KOOS (71). We 
determined that at least 63 individuals were needed in order to detect statistical significance 
using a multiple linear regression analysis if R2 = 0.17 (alpha level set at 0.05 and 80% power; 
G*Power, v3.1.9.2) (124). We recruited 66 participants to address the potential for statistical 
outliers. We estimated the 66 participants from our primary aim would allow us to find a 
moderate association (R2 = 0.25) between daily steps, MVPA, cumulative loading and KOOS 




Knee Injury and Osteoarthritis Outcomes Score (KOOS) 
 Participants completed all five subscales of the KOOS questionnaire (pain, symptoms, 
function in activities of daily living, function in sports and recreation, and knee related quality of 
life [KOOS QOL]) via a healthcare informatics system (REDCap, Vanderbilt University, 
Tennessee, USA). The KOOS questionnaire is a valid and reliable assessment of functional 
status and quality of life in individuals with ACLR. (28, 118). The KOOS was electronically 
scored to minimize processing error and each subscale was normalized to 100%, which was 
considered the best possible score for each subscale of the KOOS. Thereby higher scores 
indicated better PROs on all subscales.  
 We utilized a previous definition developed by Englund et al. (29) in an ACLR cohort to 
dichotomize participants into those with (symptomatic) and without (asymptomatic) clinically 
significant knee related symptoms. Individuals reporting KOOS QOL ≤ 87.5 as well as two or 
more of the other 4 subscales below the cut-off values (KOOS Symptoms ≤ 85.7; KOOS Pain ≤ 
86.1; KOOS ADL ≤ 86.8, KOOS Sports ≤85.0) were considered to demonstrate clinically 
significant knee related symptoms (29). Approximately, 43% (N=1530) and 39% (N=1506) of 
the individuals enrolled in the Multicenter Orthopeadic Outcomes Network (MOON) Knee 
Project cohort were symptomatic using the same criteria at 2 and 6 years following ACLR, 
respectively (30). 
 
Physical Activity Measured with Hip-Mounted Accelerometers 
 At the end of the testing session, participants were given an ActiGraph GT9X Link 
triaxial accelerometer that they were instructed to wear over the right anterior superior iliac spine 




a valid device to quantify physical activity in free-living conditions (136, 137). A valid data 
collection period was considered to be a minimum of 4 days (3 weekdays and 1 weekend day) of 
wear of no less than 10 hours per day (117). Participants removed the monitor for bathing and 
sleeping. The participants returned the monitor after the wear-period, at which time the data were 
assessed for fidelity and consistency with wear guidelines (117).  
 Average daily steps and time spent in MVPA (minutes) were processed and analyzed 
using ActiLife software (v6.13.3). Total wear time was validated using recommendations from 
Choi et al. (117) to ensure each participant wore the ActiGraph for at least 4 days for 10 hours 
per day.  Freedson Adult VM3 cut points were used to categorize physical activity as light 
(<2690 counts/minute), moderate (2690-6166 counts/minute), vigorous (6167-9642 
counts/minute), or very vigorous (>9642 counts/minute) based on the number of activity counts 
per minute during wear time (138). Cut points were then used to calculate MVPA (>2690 
counts/minute). Daily steps were assessed using vertical acceleration data measured with the 




 Participant’s barefoot vGRF was collected at a self-selected walking speed over two 
Bertec force plates (40x60cm, FP406010, Bertec Corporation, Columbus, Ohio, United States) 
embedded in a 6-meter walkway so that the entire stance phase for both limbs could be collected 
from a single trial (10, 11, 92). Participants were instructed to walk at a self-selected speed 
described as “comfortably walking over a sidewalk” and to look straight ahead maintaining a 




centered on the force plates. Once the participants felt comfortable with the task, five practice 
trials were performed to determine the average walking speed to be used during the test trials. 
During data collection participants performed five gait trials that were considered acceptable if: 
1) Both right and left feet individually made contact with a single force plate for the entirety of 
stance; 2) A forward gaze was maintained; 3) Consistent gait speed (±5%) was maintained; 4) 
Gait was not visibly altered during the trial (i.e. no tripping or stutter stepping). Force data was 
sampled at 1200 Hz and low pass filtered at 10 Hz (4th order recursive Butterworth) (24). Stance 
was defined as the interval between heel strike (vGRF > 20 N) and toe off (vGRF < 20 N). Peak 
vGRF of each trial was extracted from the first 50% of stance phase and then averaged across the 
five acceptable trials and normalized to body weight (BW). Cumulative loading was calculated 
as the product of daily steps and peak vGRF (Equation 1).  
(1)  𝐶𝑢𝑚𝑢𝑙𝑎𝑡𝑖𝑣𝑒 𝐿𝑜𝑎𝑑𝑖𝑛𝑔 =
𝐷𝑎𝑖𝑙𝑦 𝑆𝑡𝑒𝑝𝑠
2
∗ 𝑝𝑒𝑎𝑘 𝑣𝐺𝑅𝐹 
 
Statistical Analysis 
 Means and standard deviations were calculated for all continuous demographic and 
outcome variables, while frequencies were counted for all non-continuous variables. Prior to 
analysis, outliers were identified via box plots as any data point greater than three standard 
deviations from the mean. Independent t-tests were conducted for all descriptive, predictor, and 
criterion variables between asymptomatic and symptomatic cohorts. One-way analyses of 
variance were conducted for all descriptive, predictor, and criterion variables between 
asymptomatic males, symptomatic males, asymptomatic females, and symptomatic females prior 
to the post-hoc analyses. Bonferroni post-hoc comparisons were utilized to determine differences 




For our primary analyses, we conducted separate multiple regressions with each habitual 
biomechanical loading variable (daily steps, MVPA, cumulative loading) as separate criterion 
variables and each KOOS subscale as separate predictor variables. Age associates with physical 
activity (126), time from ACLR associates with the KOOS (71), and walking speed associates 
with vGRF (10). Therefore, age and time from ACLR were included as covariates in each linear 
regression equation for daily steps and MVPA. For regressions with cumulative loading as a 
dependent variable age, time from ACLR, and preferred walking speed were placed into the 
regressions as covariates prior to the KOOS subscale variable of interest. For our secondary 
analyses, separate multiple regressions were conducted between each habitual biomechanical 
loading variable and KOOS subscales as described for the primary aim within each group (i.e. 
asymptomatic and symptomatic).  
 
Post Hoc Analyses  
 Recent evidence suggests female, but not male, participants with ACLR are less 
physically active compared to uninjured controls (127).  Therefore, the cohort was stratified by 
sex and presence of clinically relevant knee symptoms into four subgroups groups (symptomatic 
females, asymptomatic females, symptomatic males, and asymptomatic males). We then 
conducted separate post-hoc multiple regressions with each habitual biomechanical loading 
variable (daily steps, MVPA, cumulative loading) as separate criterion variables and each KOOS 
subscale as separate predictor variables. The level of significance for all analyses was determined 
a priori at P<0.05 and all analyses were performed using the Statistical Package for the Social 






 Sixty-six individuals completed all aspects of the study. Descriptive, predictor, and 
criterion variables are shown for primary and secondary aims in Table 1 and for post-hoc 
analyses in Table 2. Thirty-six individuals in the entire cohort were classified as asymptomatic, 
and 30 individuals were symptomatic based on KOOS subscales. The symptomatic group 
demonstrated significantly lower KOOS subscale scores compared to the asymptomatic group, as 
expected (Table 1). The symptomatic group demonstrated less time from ACLR compared to the 
asymptomatic group (t65 = 2.22, p = 0.031, Table 1). There were no significant differences 
between groups for any dependent variables (daily steps, MVPA, cumulative loading), 
demographic variables, or walking speed. Nineteen males were asymptomatic and 11 males were 
symptomatic while 17 females were asymptomatic and 19 were symptomatic. Significant 
differences between groups existed for age (F(62,3)=3.31, p=0.026), height 
(F(62,3)=25.11,p<0.001), mass (F(62,3)=14.30,p<0.001), months post-ACLR 
(F(62,3)=5.71,p=0.002), and KOOS subscales (F(62,3) range =7.52 – 29.44, p < 0.001), which 
are shown in Table 2. 
 
Primary Analyses: Associations Between Habitual Biomechanical Loading and KOOS Subscales 
in the Entire Cohort 
 
 No significant associations were identified between the criterion variables (daily steps, 
MVPA, and cumulative loading) and the predictor variables (KOOS subscales; range ∆R2 = 







Secondary Analyses: Associations Between Habitual Biomechanical Loading and KOOS 
Subscales in Symptomatic and Asymptomatic Individuals 
 
 Greater time in MVPA associated with higher KOOS QOL (∆R2 = 0.133, B = 0.642, p = 
0.050, Figure 1, Table 3) in symptomatic individuals but not in asymptomatic individuals (∆R2 = 
0.014, β = -0.321, p = 0.472, Table 3). No other significant associations were identified in either 
the asymptomatic group (range ∆R2 = < 0.001 – 0.023, p > 0.05, Table 3) or the symptomatic 
group (range ∆R2 = < 0.001 – 0.144, p > 0.05, Table 3). 
 
Post-Hoc Analyses: Associations Between Habitual Biomechanical Loading and KOOS 
Subscales in Asymptomatic Males, Symptomatic Males, Asymptomatic Females, and 
Symptomatic Females 
 
 Greater MVPA associated with higher KOOS QOL in symptomatic females (R2 = 0.230, 
B = 0.916, P = 0.038, Figure 2, Table 4) but not in symptomatic males (R2 = 0.196, P > 0.05, 
Table 4), asymptomatic males (R2=0.045, P>0.05, Table 4),or asymptomatic females (R2 =0.008, 
P > 0.05, Table 4). Greater MVPA also associated with higher KOOS sport in symptomatic 
males (R2 = 0.470, β=1.171, P=0.020, Figure 3, Table 4). Daily steps (R2 < 0.001 – 0.210, P > 
0.05, Table 4) and cumulative loading (R2 < 0.001 – 0.285, P > 0.05, Table 4) did not associate 
with any KOOS subscales in symptomatic females, symptomatic males, asymptomatic males or 
asymptomatic females.  
 
Discussion 
Contrary to our primary hypotheses, there were no significant associations between 
KOOS subscales and daily steps, MVPA, and cumulative loading in the entire cohort. Consistent 
with our secondary hypothesis, symptomatic individuals who engaged in greater time in MVPA 




greater time in MVPA and higher KOOS QOL persisted in symptomatic females but not in 
males. Patient-reported QOL is an important outcome to monitor following ACLR, as it impacts 
multiple factors related to both return to sport and PTOA outcomes following ACLR. 
Specifically, higher KOOS QOL associates with greater peak vGRF (24, 25), better outcomes on 
clinical tests such as greater distance on single-leg hop (139), as well as psychological aspects 
such as higher self-efficacy for rehabilitation (139) and readiness to return to sport (140). 
However, this is the first study to demonstrate a significant association between greater KOOS 
QOL and time in MVPA in symptomatic individuals post-ACLR. Results from the current study 
suggest lesser self-reported QOL may impact time in MVPA that individuals choose to engage in 
following ACLR. This may have negative effects of other health related outcomes consistent 
with lesser time in MVPA.  
One potential explanation of results from the current study is that individuals with higher 
KOOS-QOL feel more confident in engaging in greater time in MVPA without fear of reinjury, 
potentially due to higher self-efficacy for exercise. Self-efficacy is the confidence in one’s ability 
to achieve and to execute an action (141), and following ACLR, athletes often demonstrate 
decreases in self-efficacy in rehabilitation (141). Individuals with higher self-efficacy for 
rehabilitation tend to demonstrate improved outcomes and patient satisfaction during ACLR 
recovery (141). Higher self-efficacy associates with higher KOOS outcomes (139), better single-
leg hop test outcomes (139), and higher self-reported activity levels one year post-ACLR (139).  
The strongest association between higher KOOS-QOL and greater MVPA was found in 
symptomatic females, potentially due to lower reported self-efficacy for rehabilitation in females 
compared to males post-ACLR (139). Females are also less likely to meet physical activity 




ACLR may be most likely to respond to future interventions aimed at increasing physical 
activity. By improving patient reported QOL, clinicians may be able to influence engagement in 
MVPA, specifically in symptomatic females. Although an individual’s QOL is multifactorial, 
greater self-efficacy for rehabilitation may be a beneficial trait for individuals aiming to increase 
physical activity during the ACLR rehabilitation process (141). Previous studies have 
successfully increased self-efficacy using techniques such as goal-setting interventions (142) and 
observational learning (143) in individuals with ACLR, and a cross-sectional study has shown 
greater self-efficacy for rehabilitation associates with daily steps in individuals with an ACLR 
(144). However, no study has evaluated if increasing self-efficacy for rehabilitation increases 
time in MVPA following ACLR. Targeting self-efficacy for rehabilitation may be a method to 
improve KOOS QOL and potentially engagement in MVPA following ACLR in symptomatic 
individuals. 
 It is also possible that participation in greater time in MPVA may facilitate higher KOOS 
scores. Aerobic exercise interventions reduce pain and disability in individuals with knee 
osteoarthritis (145, 146) potentially due to central release of endorphins (145). Although no 
aerobic exercise interventions to our knowledge have been conducted in individuals post-ACLR, 
it is possible that increasing MVPA in this patient population may improve KOOS outcomes. 
Specifically, in our post-hoc analyses, we found that symptomatic males who participated in 
greater time in MVPA demonstrated greater KOOS sport scores. The KOOS sport subscale 
measures perceived function during squatting, running, jumping, pivoting, and kneeling during 
participation in sports and physical activity (28). It is possible symptomatic males experience 
reduced stiffness and pain associated with sports-related movement due to the therapeutic 




individuals with knee osteoarthritis (147) demonstrated increases in KOOS sport following an 8-
week aerobic exercise therapy interventions. It is also possible that symptomatic individuals who 
engage in greater time in MVPA perceive less difficulty performing sports related tasks because 
they are less fearful of reinjury. Fear of reinjury is a significant barrier to return to sport 
following ACLR and may influence engagement in MVPA (148). Incorporating MVPA 
recommendations and MVPA monitoring during the ACLR rehabilitation process may result in 
greater confidence in returning to MVPA. Ability to receive feedback from the clinician as well 
as engaging in MVPA in a more controlled manner may improve psychological barriers 
associated with fear of movement post-ACLR, thereby increasing KOOS sport. 
Asymptomatic individuals did not demonstrate an association between KOOS subscales 
and daily steps, MVPA, and cumulative loading. Previous studies have demonstrated that PROs 
(International Knee Documentation Committee [IKDC] score) do not associate with daily steps 
or MVPA in individuals post-ACLR (11). These studies did not stratify participants based on 
clinically relevant symptoms, which may explain why no significant associations were found. 
Bell et al. (11) reported that the majority of their cohort demonstrated self-reported knee function 
> 85%, indicating a successful surgical outcome and suggesting that their cohort likely consisted 
of mostly asymptomatic participants. Symptomatic individuals may be more likely to 
consciously modify activities to avoid knee pain and discomfort and to adapt to limited function. 
Asymptomatic individuals are less likely to modify activities due to knee pain or difficulty. 
Asymptomatic individuals may not feel restricted to participate in physical activity based on 
their perceived QOL.  An individual’s decision to engage in MVPA is multifactorial, and 
asymptomatic individuals may not need to make decisions regarding MVPA based on knee 




cumulative loading between symptomatic and asymptomatic cohorts. Although symptomatic 
individuals do not appear to engage in less physical activity than asymptomatic individuals, 
symptomatic individuals may make more decisions regarding MVPA based on their knee related 
QOL. Therefore, symptomatic individuals may respond better to free-living physical activity 
interventions aimed at improving KOOS QOL.  
 Greater time in MVPA associates with KOOS QOL in symptomatic individuals. Daily 
steps and cumulative loading are measurements reflective of habitual walking and habitual 
biomechanical loading, which did not associate with KOOS QOL in the current study. Although 
habitual biomechanical loading may still be an important outcome post-ACLR, PROs may 
associate with MVPA because it is indicative of higher intensity movement. Symptomatic 
individuals may not make decisions about habitual walking and daily living based on their 
perceived QOL; however, they may modify engagement in MVPA to avoid pain and difficulty 
with their knee that occurs during higher intensity activities. MVPA is defined as purposeful 
movement with a metabolic equivalent of task (METs) between 3.0 – 5.9 such as brisk walking, 
cycling, mowing the lawn, weight training, yoga, or an activity that causes an elevated heart rate 
(149). In the current cohort, most individuals (n=64, 97%) met physical activity 
recommendations of 150 minutes per week of MVPA for adults aged 18-65 years (150). Bell et 
al. (11) found 97% of the ACLR cohort engaged in at least 150 minutes of MVPA per week, so 
this result was not surprising. Individuals post-ACLR may engage in less MVPA compared to 
matched uninjured controls. Return to sport is one of the most-commonly discussed clinical 
goals for patients following ACLR (135); however, little is known about long-term engagement 
in MVPA following ACLR. Approximately 56% of patients do not return to the same level of 




MVPA may be an important outcome to monitor during ACLR recovery. A reduction in physical 
activity following knee injury potentially has negative implications for long-term health 
including increased adiposity (134), decreased health-related QOL (135), and increased risk of 
chronic diseases (135); therefore MVPA may be an important outcome to target following 
ACLR in symptomatic individuals in order to maintain long-term physical health.  
 The current study is the first to demonstrate an association between KOOS QOL and 
greater time in MVPA in symptomatic individuals post-ACLR. However, there are some 
limitations that could better inform future studies. We normalized peak vGRF to BW (10, 17, 24, 
152); although results may be different when peak vGRF is not normalized to BW. Our design 
was cross-sectional in nature; therefore, we cannot determine if KOOS QOL is influenced by 
MVPA, or if MVPA is influenced by KOOS QOL. It is possible KOOS QOL and MPVA can be 
targeted simultaneously in a clinical setting to see improvements in both outcomes during ACLR 
recovery. Our sample was between 6 and 146 months post-ACLR. Time from ACLR was 
included as a covariate in all regression models as it associated with KOOS subscales, daily 
steps, MVPA, and cumulative loading. Asymptomatic individuals were significantly farther 
removed from ACLR (39±39 months) compared to symptomatic individuals (16±14 months). 
Future studies may analyze patients earlier in the recovery process or stratify participants based 
on time from ACLR. In our post-hoc analyses, asymptomatic and symptomatic males 
demonstrated greater age, height, and mass compared to asymptomatic females. These 
descriptive variables were not included as covariates in our post-hoc analyses as this was a 
preliminary study and we did not want to overfit our linear regression models. While our study 
indicates that the associations between MVPA loading and PROs may be influenced by sex and 




multiple covariates may impact these relationships. KOOS-QOL seems to be influenced by self-
efficacy and fear of reinjury (141). Future studies should incorporate measures of self-efficacy 
and fear of reinjury when addressing physical activity outcomes post-ACLR. Additionally, 
results from the current study suggest the need to longitudinally evaluate KOOS and MVPA 
throughout ACLR recovery.  
 
Conclusions 
 There was no significant association between KOOS subscales and daily steps, MVPA, 
or cumulative loading in the entire cohort. When stratified based on presence of clinically 
relevant symptoms, symptomatic individuals with greater KOOS QOL demonstrated greater time 
in MVPA. When further stratified by sex, symptomatic females demonstrated the strongest 
association between greater KOOS QOL and greater time in MVPA. Patient-reported QOL and 
time spent in MVPA may be outcomes to target with therapeutic interventions in symptomatic 




Table 7. Descriptive, Independent, and Dependent Variables in Asymptomatic and 













Age (years) 22±4 22±4 22±5 
Height (m) 1.71±0.1 1.71±0.09 1.71±0.09 
Mass (kg) 71.3±12.6 71.2±14.2 71.5±10.5 
Body Mass Index (kg/m2) 24.2±2.9 24.0±2.9 24.4±2.8 
Months post-ACLR 28±33 39±39 15.7±14.5 * 












Walking speed (m/s) 1.25±0.11 1.25±0.11 1.25±0.12 
KOOS symptoms 82.0±13.7 90.3±7.6 72.0±12.9 * 
KOOS pain 90.1±7.8 95.3±3.6 83.8±6.8 * 
KOOS activities of daily living 96.6±5.4 99.1±1.7 93.7±6.8 * 
KOOS sport 79.2±16.6 89.3±9.3 67.2±15.3 * 
KOOS quality of life 69.6±19.0 81.8±11.8 55.0±15.4 * 
Daily steps 8602±2466 8881±2584 8266±2316 
Moderate to vigorous physical 
activity (minutes) 
69±26 72±27 66±25 
Cumulative loading (involved 
limb) BW*steps/day 
4641±1411 4873±1511 4364±1250 
ACLR – anterior cruciate ligament reconstruction; KOOS – Knee Injury and Osteoarthritis 
Outcome Score; BW – Body Weight (Newtons), BPB – bone-patellar-tendon-bone autograft, 
H – Semitendinosus autograft, A – allograft, Q – Quadriceps tendon autograft 





Table 8. Descriptive, Independent, and Dependent Variables in Asymptomatic and 









Age (years) 23±4 23±5 20±2 * 21±4 
Height (m) 1.78±0.07 1.80±0.06 1.64±0.05 *# 1.66±0.07 *# 
Mass (kg) 80.3±12.7 78.7±9.6 61.0±7.3 *# 67.3±8.8 *# 
Body Mass 
Index (kg/m2) 
25.2±3.0 24.4±2.2 22.7±2.2 * 24.4±3.2 
Months post-
ACLR 
51±48 9±4 * 25±22 * 19±17 * 
Graft Type     
Walking speed 
(m/s) 
1.26±0.08 1.25±0.13 1.25±0.14 1.24±0.11 
KOOS 
symptoms 
91.9±7.0 72.1±10.8 * 88.4±7.9 # 72.0±14.2 *$ 
KOOS pain 96.3±3.1 86.4±7.3 * 94.1±3.9 # 82.3±6.2 *$ 
KOOS activities 
of daily living 
99.5±1.1 95.2±3.9 
 
98.7±2.2 92.9±8.0 *$ 
KOOS sport 89.5±7.8 68.6±11.2 * 89.1±10.9 # 66.3±17.5 *$ 
KOOS quality of 
life 
85.2±11.3 50.0±16.1 * 77.9±11.5 # 57.9±14.7 *$ 










4820±1294 4400±1168 4932±1762 4343±1327 
ACLR – anterior cruciate ligament reconstruction; KOOS – Knee Injury and Osteoarthritis 
Outcome Score; BW – Body Weight (Newtons) 
*significantly different from asymptomatic males (p<0.05) 
#significantly different from symptomatic males (p<0.05) 









Table 9. Associations Between Daily Steps, MVPA, Cumulative Loading and KOOS Subscales in the Entire Cohort, Asymptomatic and Symptomatic 
Individuals Post-ACLR 
 Daily Steps MVPA (minutes) Cumulative Loading (BW/day) 
Entire 
Cohort 
Asymptomatic Symptomatic Entire 
Cohort 























































































































































MVPA – moderate to vigorous physical activity; ACLR – anterior cruciate ligament reconstruction; KOOS – Knee Injury and Osteoarthritis Outcome Score; 
BW – Body Weight (Newtons) 






Table 10. Associations Between Daily Steps, MVPA, Cumulative Loading and KOOS 
Subscales in Asymptomatic Males, Symptomatic Males, Asymptomatic Females, and 
Symptomatic Females Post-ACLR 







































































































































































































































MVPA – moderate to vigorous physical activity; ACLR – anterior cruciate ligament 
reconstruction; KOOS – Knee Injury and Osteoarthritis Outcome Score; BW – Body Weight 
(Newtons) 





Figure 2: Symptomatic individuals post-anterior cruciate ligament reconstruction (ACLR) who 
demonstrate greater knee injury and osteoarthritis outcome quality of life (KOOS-QOL) scores 
demonstrate greater time spent in moderate-vigorous physical activity (MVPA). 






Figure 3: Symptomatic females post-anterior cruciate ligament reconstruction (ACLR) who 
demonstrate greater knee injury and osteoarthritis outcome quality of life (KOOS-QOL) scores 
demonstrate greater time spent in moderate-vigorous physical activity (MVPA). 
 





Figure 4: Symptomatic males post-anterior cruciate ligament reconstruction (ACLR) who 
demonstrate greater knee injury and osteoarthritis outcome sport (KOOS-QOL) function, sports 




















































Daily Steps, Moderate to Vigorous Physical Activity, and Cumulative Loading Associate with 





 Individuals with an anterior cruciate ligament (ACL) injury who have undergone ACL 
reconstruction (ACLR) demonstrate altered biomechanical loading in the ACLR limb during 
walking gait compared to their contralateral limb and to uninjured controls (16, 153–155).  
Specifically, individuals demonstrate lesser peak vertical ground reaction force (vGRF) (155), 
peak knee flexion angle (KFA) and peak internal knee extension moment (KEM) during the first 
50% of stance phase (82, 83, 156). These changes in biomechanical loading during walking alter 
the magnitude of tibiofemoral contact force (Saxby et al., 2016; Wellsandt et al., 2016), which 
may contribute to the development of irreversible cartilage damage over time (5, 158). 
Alterations in biomechanical loading, specifically peak vGRF, may influence outcomes related 
to PTOA, as peak vGRF in the first 50% of stance phase is associated with joint tissue 
metabolism (9, 10), femoral cartilage thickness (26), and femoral cartilage composition (17, 65). 
As two-thirds of individuals with ACLR develop PTOA within 2 decades of initial injury (Luc et 
al., 2014), developing interventions aimed at restoring normal loading to injured joint tissues is 
critical. 
 Although multiple studies have evaluated biomechanical loading in individuals post-
ACLR over a single step in a laboratory setting (16, 155), this may not reflect habitual 




intensity of biomechanical loading may be estimated with objectively-measured physical activity 
outcomes such as daily steps and time spent in moderate to vigorous physical activity (MVPA), 
respectively (11, 133, 159). A recent cross-sectional study of individuals ranging 6-66 months 
post-ACLR found that those with and ACLR engaged in fewer daily steps and less time spent in 
MVPA compared to age and sex matched uninjured controls (11). Reductions in daily steps and 
MVPA following ACLR may decrease the overall volume of loading to joint tissues. 
Additionally, cumulative loading, a measure that combines frequency of loading (daily steps) 
and magnitude of loading (peak vGRF) can be used as an estimate of habitual biomechanical 
loading (14, 18). Estimating habitual biomechanical loading via daily steps, MVPA, and 
cumulative loading is an important step in determining optimal biomechanical loading following 
ACLR. While it is known that peak vGRF associates with multiple outcomes related to knee 
articular cartilage degradation, it is unknown how habitual biomechanical loading associates with 
joint tissue metabolism and femoral articular cartilage deformation caused by walking. 
 Serum cartilage oligomeric matrix protein (COMP) is a mechanosensitive biomarker that 
helps stabilize the articular cartilage during biomechanical loading (61), and increases in serum 
COMP concentrations have been found immediately following 30 minutes of walking at a self-
selected speed (114, 160). Greater resting concentration of synovial fluid COMP may be 
indicative of greater cartilage degradation post-ACLR (61), and greater increases in serum are 
associate with greater unbinding of COMP from the articular cartilage in the knee synovial joint 
(161), which may indicate a reduced ability for knee cartilage to resist deformation during 
biomechanical loading (160, 162). Greater %ΔCOMP following biomechanical loading 
associates with greater cartilage thinning over 5 years (162). Lesser peak vGRF during a single 




walking protocol in individuals post-ACLR (40), indicating insufficient biomechanical stimulus 
may associate with less conditioned articular cartilage. Additionally, ultrasonography measures 
of anterior femoral articular cartilage cross-sectional area (CSA) have been used to evaluate the 
capacity of the tissue to resist compression by evaluating the percent change in CSA (%ΔCSA) 
following a standardized walking protocol (38, 116, 119). In healthy participants, medial femoral 
condyle articular cartilage CSA decreases approximately 6.7% in the immediately following 
3,000-steps of treadmill walking (38). A previous study reported that greater peak vGRF during a 
single step associated with greater resting femoral cartilage thickness in individuals post-ACLR 
(26), but it remains unknown how %ΔCSA following a standardized walking protocol associates 
with habitual biomechanical loading in individuals post-ACLR.  
 Greater peak vGRF during a single step associates with lesser %ΔCOMP following a 
standardized walking protocol (40), suggesting greater magnitude of biomechanical loading may 
condition articular cartilage to better resist loading during a standardized walking protocol. 
Therefore, the primary purpose of the current study was to determine if there is an association 
between habitual biomechanical loading variables (daily steps, MVPA, and cumulative loading) 
and knee cartilage response to loading (%∆COMP and %∆CSA) following a standardized 
walking protocol in individuals within 18 months post-ACLR. We hypothesized that greater 
daily steps, time in MVPA, and cumulative loading would associate with lesser %∆COMP and 
%∆CSA in individuals post-ACLR. Sex influences associations between biochemical makers of 
joint tissue metabolism, body mass index (41), and months between ACL injury (42). Therefore, 
an exploratory secondary purpose of this study was to determine the associations between 
habitual biomechanical loading variables and knee cartilage response variables separately in 






 In this cross-sectional study, individuals post-ACLR completed two laboratory testing 
sessions 17±12 days apart. Demographic variables, preferred walking speed, and vGRF, used to 
calculate cumulative loading, were collected during the initial session (Figure 1). For the second 
testing session, serum COMP and femoral articular cartilage CSA were collected immediately 
before and immediately following a standardized walking protocol in order to determine 
%∆COMP and %∆CSA (Figure 1). Daily steps and MVPA were assessed using an ActiGraph 
GT9X Link triaxial accelerometer worn outside of the laboratory for a 7-day period, which 
began immediately following the initial session (Figure 1). The Institutional Review Board at our 
institution approved all methods, and all participants provided written consent prior to 
participation. 
 
Participants and Power Analysis 
 Individuals were included if they had undergone unilateral ACLR using a patellar tendon 
autograft within the past 6-18 months prior to data collection and had physician approval to 
return to participation in physical activity. All participants were between the ages of 18-35 years 
with a BMI ≤ 35 kg/m2. Individuals were excluded if they were currently pregnant, had been 
previously diagnosed with any form of inflammatory arthritis, needed a multi-ligament 
reconstruction, or had previous history of ACLR on either limb. Demographic data are provided 
in Table 1. We estimated a moderate association would be detected between daily steps, MVPA, 
and cumulative loading with %ΔCOMP and %ΔCSA based on previous data (40) which found a 




%ΔCOMP following a treadmill walking protocol. Therefore, we estimated 34 individuals were 
needed to detect a moderate association with an an alpha level of 0.05 and 80% power 
(G*Power, v3.1.9.2) (Faul et al., 2007). We recruited an additional 2 participants (N=36) to 
maintain statistical power in the event outliers were removed from the final dataset or data points 
were missing due to the inability to obtain blood samples.  
 
Vertical Ground Reaction Force 
 vGRF was collected during shod walking at a self-selected speed over two Bertec force 
plates (40x60cm, FP406010, Bertec Corporation, Columbus, Ohio, United States) embedded in a 
6-meter walkway so the entire stance phase for both limbs could be collected from a single trial 
(9, 10, 92). Participants were instructed to walk at a self-selected speed described as 
“comfortably walking over a sidewalk” and to look straight ahead maintaining a constant speed 
through two sets of infrared timing gates (TF100, Trac Tronix, Lenexa, Kansas) centered on the 
force plates. Once the participants felt comfortable with the task, five practice trials were 
performed to determine the average walking speed to be used during the test trials. During data 
collection participants performed five gait trials that were considered acceptable if: 1) Both right 
and left feet individually made contact with a single force plate for the entirety of stance; 2) A 
forward gaze was maintained; 3) Consistent gait speed (±5%) was maintained; 4) Gait was not 
visibly altered during the trial (i.e. no tripping or stutter stepping). Force data was sampled at 
1200 Hz and low pass filtered at 10 Hz (4th order recursive Butterworth) (24). Stance was 
defined as the interval between heel strike (vGRF > 20 N) and toe off (vGRF < 20 N). Peak 
vGRF of each trial was extracted from the first 50% of stance phase and then averaged across the 




Objectively Measured Physical Activity 
 Participants were given an ActiGraph GT9X Link triaxial accelerometer. Participants 
wore the accelerometer over the right anterior superior iliac spine for seven consecutive days 
immediately following the study visit. The ActiGraph GT9X Link is a valid device to quantify 
physical activity in free-living conditions (136, 137). A valid data collection period was 
considered to be a minimum of 4 days (3 weekdays and 1 weekend day) of wear with no less 
than 10 hours per day (159). The participants returned the monitor after the wear-period, at 
which time the data were assessed for fidelity and consistency with wear guidelines. Average 
daily steps and time in MVPA (measured in minutes) were processed and analyzed using 
ActiLife software (v6.13.3). Total wear time was validated using Choi et al. (117) 
recommendations in order to ensure each participant wore the ActiGraph for at least 4 days for 
10 hours a day.  Freedson Adult VM3 cut points were used to categorize MVPA as >2690 
counts/minute (138). Daily steps were assessed using vertical acceleration data measured with 
the ActiGraph monitor. Variables were then normalized to the number of wear days to create a 
daily average (11). Cumulative loading was calculated as the product of daily steps and peak 
vGRF (Equation 1) (14).  
(1)  𝐶𝑢𝑚𝑢𝑙𝑎𝑡𝑖𝑣𝑒 𝐿𝑜𝑎𝑑𝑖𝑛𝑔 =  
𝐷𝑎𝑖𝑙𝑦 𝑠𝑡𝑒𝑝𝑠
2
∗ 𝑝𝑒𝑎𝑘 𝑣𝐺𝑅𝐹                                                                           
 
Ultrasound Measures 
Upon arrival to the laboratory, participants rested on a treatment table with their knees in 
full extension for 45 minutes to unload the cartilage and minimize effects of preceding activity 
on the cartilage (119). After 45 minutes, participants were positioned supine with their knees 




secured to the top of the table and used to ensure that the head, hip and heel of the foot were 
aligned at the same point on the table before and after the standardized walking protocol (Figure 
2). A LOGIQe US system (General Electric Co., Fairfield, CT) with a 12 MHz linear probe was 
used to obtain 3 images of the anterior portion of the femoral articular cartilage in the ACLR 
limb. The probe was placed transversely in line with the medial and lateral femoral condyles 
above the superior edge of the patella and rotated to maximize reflection of the articular cartilage 
surface (38, 119). Images were obtained immediately before (CSAPRE) and immediately (within 
5 minutes) following (CSAPOST) the standardized walking protocol.  
 
Ultrasound image analysis 
 Ultrasound images were processed using ImageJ software (National Institutes of Health, 
Bethesda, MD). The femoral cartilage was segmented by individually identifying the entire 
visualized cartilage–bone interface and soft tissue–cartilage interface for the cartilage of the 
femur to obtain the cartilage CSA (mm2, Figure 3). CSA from each of the 3 images was averaged 
to create mean CSAPRE and a CSAPOST values. A percent change score from baseline to each 
post-test time point was calculated following the standardized loading protocol (%ΔCSA). A 
greater negative percentage change in CSA indicated greater cartilage deformation and more 
positive percent change indicated greater cartilage swelling (Equation 2). 
(2)   %𝛥𝐶𝑆𝐴 =
𝐶𝑆𝐴𝑝𝑜𝑠𝑡−𝐶𝑆𝐴𝑝𝑟𝑒
𝐶𝑆𝐴𝑝𝑟𝑒
∗ 100   
 
Serum Collection and Analysis of Cartilage Oligomeric Matrix Protein (COMP) 
 Five milliliters of antecubital venous blood were collected via a standard vacutainer 




standardized walking protocol. Serum tubes were placed on ice until centrifuged at 4 °C for 10 
min at 3000g (120). Serum was pipetted equally into two 1.5 mL cryovials and stored in a −80 
°C freezer for batch analysis following completion of the study. Serum COMP concentration was 
assessed via a commercially available specific enzyme-linked immunosorbent assay (ELISA) 
(BosterBio, Pleasanton, CA) with an assay detection sensitivity of<10 pg/mL. For all assays, 
unknown samples were diluted 100x and all standards, samples, and controls were performed in 
duplicate determinations. All assays demonstrated an average intra-assay variability of 2.8%, and 
all assays demonstrated an intra-assay variability <10.6%. We calculated percent change scores 
in COMP following the loading session to determine %∆COMP (Equation 3).  
(3)   %𝛥𝐶𝑂𝑀𝑃 =
𝐶𝑂𝑀𝑃𝑝𝑜𝑠𝑡−𝐶𝑂𝑀𝑃𝑝𝑟𝑒
𝐶𝑂𝑀𝑃𝑝𝑟𝑒
 𝑥 100               
 
Treadmill Walking Protocol 
 The standardized walking protocol was adapted from previous literature (102, 114).  
Participants were positioned on the treadmill and speed was increased at 0.5 m/s up to their 
preferred walking speed determined during the vGRF assessment. Participants walked at this 
speed for 3,000 steps. Once the participant reached 3,000 steps, the treadmill was slowed at 0.5 
m/s to a stop. The table was placed approximately 2m away from the treadmill to minimize steps 
taken between the treadmill and plinth. An average of 3017±14 steps were taken across the 
sample, including moving onto and off the treadmill to the plinth. Once the participant reached 








 Data points ≥ 3 standard deviations from the mean were considered statistical outliers and 
removed from subsequent analyses. Means and standard deviations were calculated for all 
continuous variables, and frequencies were counted for non-continuous variables. Independent t-
tests were conducted for all descriptive, predictor, and criterion variables between males and 
females prior to the primary analyses. Walking speed was included as a covariate in each linear 
regression, as this variable has been reported to associate with biomarkers of joint tissue 
metabolism (9) and composition (17).  
For the primary analyses, separate multiple regression models were constructed to 
determine the unique associations between habitual biomechanical loading variables (daily steps, 
MVPA, and cumulative loading) and measures of knee cartilage response to loading (%∆CSA 
and %∆COMP). Separate regression equations were constructed using %∆CSA and %∆COMP 
as predictor variables and daily steps, MVPA, and cumulative loading were individually 
evaluated as criterion variables. Walking speed was added to each regression equation prior to 
the predictor variable of interest. We evaluated the change in R2 (∆R2) and unstandardized beta 
(β) in the criterion variable (%∆COMP or %∆CSA) from each predictor variable (daily steps, 
MVPA, or cumulative loading) after accounting for the variance from walking speed. Sex has 
been shown to influence biochemical markers of joint tissue metabolism following ACLR (42). 
Therefore, as a secondary analysis, the cohort was stratified by sex, and multiple regression 







Post Hoc Analyses 
Results from the primary analysis revealed that CSA did not decrease in all participants 
following the walking protocol. Based on previously calculated minimal detectable change in 
CSA associated with this same walking protocol (MDC, ≥ 3.82 mm2) (102) we stratified the 
entire cohort based on the magnitude of change in CSA (CSAPOST - CSAPRE). Participants who 
demonstrated a decrease in CSA of at least 3.82 mm2 were defined as deformers, while those 
who did not deform by at least 3.82 mm2 were classified as non-deformers. We then conducted 
post-hoc two-tailed independent t-tests to determine if there were differences in daily steps, 
MVPA, or cumulative loading between deformers and non-deformers. We also calculated 
Cohen’s d effect sizes due to the small sample size of the deformer group; d=0.20 was 
considered a small effect, d=0.5 was considered a medium effect, and d=0.8 was considered a 
strong effect size. (163) Statistical significance was determined a priori as P ≤ 0.05, and all 
statistical analyses were performed using the Statistical Package for the Social Sciences software 
(SPSS, Version 21, IBM Corp., Somers, NY). 
 
Results 
 No outliers were identified for any predictor or criterion variables. Demographics, 
habitual biomechanical loading, and knee cartilage response variables for the entire cohort as 
well as males and females are shown in Table 1. Males were older (t34=2.80, p=0.008), taller 
(t34=6.59, p<0.001), and more massive (t34=3.94, p<0.001) compared to females. Males also 
demonstrated greater time in MVPA (t34=2.05, p=0.048), greater CSAPRE (t34=5.20, p<0.001), 





Primary Analysis: Associations in Entire Cohort 
 After accounting for walking speed, daily steps, MVPA, and cumulative loading did not 
significantly associate with %∆COMP in individuals post-ACLR (ΔR2 range: 0.068 – 0.088, 
P>0.05, Table 2). Similarly, daily steps, MVPA, and cumulative loading did not significantly 
associate with %∆CSA (ΔR2 range: 0.002 – 0.041, P>0.05, Table 2).  
 
Secondary Analysis: Associations in Males and Females 
 Males who engaged in greater daily steps (ΔR2=0.382, β=-0.005, P=0.013, Table 3 
Figure 4), greater time in MVPA (ΔR2=0.281, β=-0.452, P=0.040, Table 3 Figure 5), and greater 
cumulative loading (ΔR2=0.421, β=-0.009, P=0.008, Table 3 Figure 6) demonstrated lesser 
%∆COMP. Daily steps, MVPA, and cumulative loading did not significantly associate with 
%∆COMP in females (ΔR2 range: <0.001 – 0.015, P>0.05, Table 3) and did not association with 
%∆CSA in males (ΔR2 range: 0.034 – 0.057, P>0.05, Table 3) or females (ΔR2 range: 0.018 – 
0.036, P>0.05, Table 3). 
 
Post Hoc Analysis: Differences in habitual biomechanical loading between deformers and non-
deformers 
 
 Seven participants were classified as deformers (CSAPOST-CSAPRE= -7.40±4.92mm
2) 
while 29 participants were classified as non-deformers (CSAPOST-CSAPRE= 1.42±2.80mm
2). 
There was no significant difference between daily steps (non-deformers=8043±2325 steps, 
deformers = 6697±1588 steps, t34=1.44, p=0.158, effect size [ES]:d=0.68), MVPA (non-
deformers=62±24 minutes/day, deformers=56±19 minutes/day, t34=0.61, p=0.543. d=0.28), or 
cumulative loading (non-deformers=4439±1379 BW/day, deformers=3608±1004 BW/day, 





Contrary to our primary hypotheses, there were no significant associations between daily 
steps, MVPA, or cumulative loading and %∆COMP and %∆CSA following walking in the entire 
cohort. After stratifying by sex, males who engaged in greater daily steps, greater time in 
MVPA, and greater cumulative loading demonstrated lesser %∆COMP but did not demonstrate 
significant associations between habitual biomechanical loading and %∆CSA. Females did not 
demonstrate significant associations between habitual biomechanical loading variables and 
%∆COMP or %∆CSA. Our post hoc analysis indicated that those who were classified as 
deformers did not demonstrate significant differences in daily steps, MVPA, or cumulative 
loading compared to non-deformers; however there were moderate effect sizes for daily steps 
and cumulative loading between deformers and non-deformers with a power of 0.035 (124), 
suggesting the need for a larger study to detect differences in habitual biomechanical loading 
between deformers and non-deformers based on %ΔCSA following a standardized walking 
protocol. It is estimated we would need 28 deformers and 28 non-deformers to detect statistical 
significance and maintain power of 0.80 (124). This study is the first to our knowledge to 
determine associations between habitual biomechanical loading and %ΔCOMP in males 6-18 
months post-ACLR. These results suggest that greater habitual biomechanical loading following 
ACLR may influence knee cartilage response to loading. Future studies should evaluate if 
increasing habitual biomechanical loading reduces knee cartilage response to loading following a 
standardized walking protocol. 
Serum COMP is a biochemical marker often used to evaluate knee cartilage response to 
loading (39, 40, 160, 162). COMP binds to type-II collagen within the extracellular matrix to 




response to a biomechanical stimulus (160). Once COMP is unbound from type-II collagen, it 
may exit the extracellular matrix due to fluid shifts caused by the biomechanical stimulus of 
walking or running (160, 161). In a previous study, COMP concentrations increased in serum 
while decreasing in synovial fluid following a standardized running protocol, indicating a 
biomechanical stimulus such as running may facilitate movement of COMP from the 
extracellular matrix into the systemic system which can be measured in serum (161). Greater 
%∆COMP following a standardized walking protocol associates with greater decreases in 
articular cartilage thickness in individuals with KOA, suggesting that greater %∆COMP may be 
related to morphological change in type-II collagen (162). Additionally, resting serum COMP is 
greater in individuals with KOA compared to controls, and greater COMP is associated with 
greater severity of KOA, indicating COMP is higher in individuals who have experienced 
significant type-II collagen degradation (164, 165). Following ACLR, decreased proteoglycan 
density and increased water content of the articular cartilage occurs within the first 12 to 18 
months following ACLR (64, 166). Type-II collagen degeneration may not occur until after 
changes in proteoglycan density has occurred (50, 60). It is possible that COMP response 
following walking may not be altered within the current cohort, who are 8±2 months post-ACL, 
because type-II collagen within the articular cartilage is not yet altered. Future studies may 
determine if this association is present in individuals greater than 8±2 months post-ACLR.   
This is the first study to our knowledge to demonstrate significant associations between 
%∆COMP and daily steps, MVPA, and cumulative loading in males post-ACLR. Females did 
not demonstrate any significant associations between habitual biomechanical loading variables 
and knee cartilage response outcomes. It is unclear why %ΔCOMP does not associate with 




based on sex and ethnicity in individuals with KOA, specifically Caucasian males demonstrate 
greater resting serum COMP compared to Caucasian females (167). Additionally, synthetic 
estrogen has been shown to reduce serum COMP in older women (168), suggesting estrogen 
levels effect cartilage metabolism. There were no differences in serum COMP between African 
American males and females (167). However, no study has previously evaluated sex differences 
in %ΔCOMP in uninjured controls, individuals post-ACLR or individuals with KOA due to 
limited sample size (162, 169). Future studies should evaluate longitudinal sex differences in 
%ΔCOMP in individuals following ACLR to elucidate when associations between habitual 
biomechanical loading and %ΔCOMP begin to differ between males and females. Another 
potential explanation for sex differences regarding associations between habitual biomechanical 
loading and %ΔCOMP is that males in our study spent significantly greater minutes in MVPA 
(69±21 minutes/day) compared to female participants (54±23 minutes/day). MVPA is defined as 
purposeful movement with a metabolic equivalent of task (METs) between 3.0 – 5.9 such as 
brisk walking, cycling, mowing the lawn, weight training, yoga, or an activity that causes an 
elevated heart rate (149). One hypothesis is that males who engage in greater time in MVPA are 
likely exposed to greater habitual biomechanical loading. Therefore, articular cartilage in males 
may be more conditioned to experiencing these higher volumes of biomechanical loading and 
consequently demonstrate lesser %ΔCOMP following a standardized walking protocol. Results 
from the current study suggest that habitual biomechanical loading may be an important outcome 
to monitor post-ACLR when aiming to minimizing COMP response during a standardized 
walking protocol, specifically in males. Understanding appropriate biomechanical loading not 
only with laboratory-based measures, but also with measures of habitual biomechanical loading, 




 Within one year following ACLR many individuals demonstrate decreased proteoglycan 
content measured with MRI T1rho relaxation times (63, 74). Previous cross-sectional studies 
have demonstrated that lesser peak vGRF and lesser peak KAM during walking gait associate 
with worse knee cartilage biomarker outcomes (10) as well as worse MRI T1rho relaxation times 
(17) within one-year post-ACLR. It is hypothesized that the association between lesser lower 
extremity loading and worse knee cartilage biomarker and MRI outcomes may be due to changes 
in cartilage homeostasis signaled by insufficient biomechanical stimulation of joint tissues (170). 
Healthy articular cartilage becomes conditioned to habitual biomechanical loading, with thicker 
articular cartilage corresponding to regions of the joint surface that experience the greatest 
loading (88, 171). Conversely, insufficient biomechanical loading may result in cartilage atrophy 
(172), induced by a pro-inflammatory response that increases the expression of degenerative 
enzymes involved in cartilage breakdown (172). Although studies have shown that appropriate 
biomechanical loading is important post-ACLR (9, 10, 170, 172), this is the first study to 
evaluate habitual biomechanical loading, which incorporates both frequency of loading and 
magnitude of loading, post-ACLR. Results from the current study suggest engagement in greater 
habitual biomechanical loading post-ACLR associates with a more beneficial COMP response 
following walking in males post-ACLR. Habitual biomechanical loading is likely an important 
component to consider when creating interventions aimed at restoring appropriate biomechanical 
loading in individuals post-ACLR. 
COMP is a binding protein in the articular cartilage extracellular matrix that plays an 
important role in stabilizing the cartilage matrix during load-bearing activities such as walking, 
running, and jumping (173). The current study used a standardized walking protocol as a method 




stimulus-response model in a laboratory setting allows for the measurement of knee cartilage 
response to physiological demands that cannot be measured with resting biomarker 
concentrations.  In the current study the entire cohort demonstrated a 10% increase in COMP 
concentration during the walking protocol. Mundermann et al. (160) has shown a similar 10% 
increase in COMP following a standardized walking protocol on a level outdoor walking track in 
uninjured control participants. Luc-Harkey et al. reported that greater peak vGRF during a single 
step of walking associated with lesser %ΔCOMP following a standardized walking protocol in 
individuals post-ACLR, which supports the significant association between greater habitual 
biomechanical loading and %ΔCOMP found in our male cohort. Celik et al. found that COMP 
response decreased after 12 weeks of a running intervention in healthy uninjured males (174). 
Results from Celik et al. and the current study support the hypothesis that habitually engaging in 
greater volumes of loading associates with less COMP response following a loading protocol and 
that articular cartilage may undergo beneficial physiological adaptation with load-bearing 
training such as running. It remains unknown if articular cartilage can undergo beneficial 
physiological adaptations with proper amounts of habitual biomechanical loading following 
ACLR. Interventions aimed at restoring appropriate amounts of biomechanical loading are of 
high importance for maintaining knee cartilage health post-ACLR, but more information 
regarding habitual biomechanical loading post-ACLR is needed.  
There were no significant associations between habitual biomechanical loading and 
%∆CSA in the entire cohort or in males and females separately. Anterior femoral articular 
cartilage deformation has been evaluated with ultrasound in several studies evaluating uninjured 
controls (38, 119, 175). Most participants in these studies demonstrated a 6.7% decrease in 




participants decreased CSA by a MDC of at least 3.82 mm2. Post-hoc analyses revealed no 
difference in daily steps, MVPA, or cumulative loading between deformers and non-deformers; 
however, moderate effect sizes were found for daily steps and cumulative loading between 
deformers and non-deformers. A previous study reported a similar occurrence in uninjured 
controls following a standardized walking protocol (176). Investigators analyzing ultrasound 
images in the current study were blinded to whether the images were obtained pre or post 
walking. Previous studies were not blinded (26, 38, 102), and blinding to image analyses affects 
magnitude of change in MRI (177) and radiographs (178). Therefore, blinding the ultrasound 
images during analysis increases the scientific rigor compared to previous studies that have 
evaluated %∆CSA. Individuals with ACLR demonstrate greater femoral articular cartilage CSA 
and thickness measured with ultrasound compared to uninjured controls (115). Greater resting 
femoral articular cartilage CSA and thickness may be due to swelling or hypertrophy that occurs 
post-ACLR (115). No study to our knowledge has measured %∆CSA of femoral articular 
cartilage using ultrasound in individuals post-ACLR; therefore, it is unknown if an increase in 
CSA is common in individuals post-ACLR. It is likely that the heterogenous response in the 
current study may impact the detection of associations that exist between %∆CSA and habitual 
biomechanical loading outcomes. Future studies should evaluate differences between individuals 
post-ACLR who display decreases vs. increases in femoral cartilage CSA following walking.  
 The current study is the first to demonstrate associations between %∆COMP and daily 
steps, time in MVPA, and cumulative loading in males post-ACLR. However, there are some 
limitations that could better inform future studies. Age, height, and mass were significantly 
different between males and females (Table 1), but due to our small sample size, we did not 




Rather than knee synovial fluid, we measured COMP from serum, which can be influenced by 
systemic alterations in COMP rather than knee specific changes. Our design was cross-sectional, 
so it is unknown if increasing habitual biomechanical loading decreases %∆COMP following 
walking. There is still a need for a longitudinal study to evaluate habitual biomechanical loading 
and COMP response throughout ACLR recovery. 
 
Conclusions 
 There were no significant associations between %∆COMP, %∆CSA, daily steps, MVPA, 
and cumulative loading in our entire cohort. However, males who engaged in greater daily steps, 
greater time in MVPA, and greater cumulative loading demonstrated less %∆COMP following a 
3000-step standardized walking protocol. A greater amount of habitual biomechanical loading 
may be an important component to consider when aiming to reduce COMP response in males 




Table 11. Descriptive, Independent, and Dependent Variables 
 Entire Cohort (N=36) Males (n=20) Females (n=16) 
Age (years) 22±4 24±5 20±3 * 
Height (m) 1.71±0.10 1.78±0.08 1.64±0.05 * 
Mass (kg) 71.6±12.4 79.2±11.5 65.5±9.5 * 
Body Mass Index 
(kg/m2) 
24.5±2.8 24.8±2.2 24.2±3.3 
Time post-ACLR 
(months) 
8±2 9±2 8±3 
Walking speed (m/s) 1.28±0.11 1.29±0.09 1.28±0.12 
Daily Steps 7781±2247 7930±2099 7662±2405 
MVPA (minutes) 61±23 69±21 54±23 * 
Cumulative Loading 
(BW/day) 
4277±1343 4426±1252 4158±1432 
COMPPRE (ng/mL) 151.3±48.1 158.1±54.7 145.8±42.7 
COMPPOST (ng/mL) 165.7±56.2 174.2±63.6 158.8±50.0 
%ΔCOMP 10.4±18.9 11.0±17.8 9.9±20.2 
CSAPRE (mm
2) 80.6±17.8 93.4±16.6 70.1±10.6 * 
CSAPOST (mm
2) 80.2±17.8 93.4±16.6 69.8±10.3 * 
%ΔCSA  -0.25±5.6 -0.05±6.58 -0.40±4.87 
ACLR – Anterior Cruciate Ligament Reconstruction, MVPA – Moderate to vigorous physical 
activity, BW – Body Weight, COMPPRE – Resting cartilage oligomeric matrix protein, 
COMPPOST – cartilage oligomeric matrix protein following walking , %∆COMP = Percent 
change in cartilage oligomeric matrix protein, CSAPRE – resting cross-sectional area, CSAPOST 
– cross-sectional area following walking, %∆CSA – percent change in cross-sectional area 





Table 12. Linear Regression Models Adjusted for Walking Speed Between Habitual 
Biomechanical Loading and Knee Cartilage Loading Response Variables 
 Biomechanical Loading Variables 









%∆COMP ∆R2 0.073 0.068 0.088 
β -0.002 -0.226 -0.005 
P 0.105 0.117 0.074 
%∆CSA ∆R2 0.041 0.002 0.040 
β 0.001 0.011 0.001 
P 0.241 0.808 0.247 
MVPA – Moderate to vigorous physical activity, BW – Body weight, %∆COMP = Percent 
change in cartilage oligomeric matrix protein, %∆CSA – percent change in knee cartilage 





Table 13. Linear Regression Models Adjusted for Walking Speed Between Habitual 
Biomechanical Loading and Knee Cartilage Loading Response Variables in Males and 
Females 
 Biomechanical Loading Variables 









%∆COMP Males ∆R2 0.382 0.281 0.421 
β -0.005 -0.452 -0.009 
P 0.013 * 0.040 * 0.008 * 
Females ∆R2 < 0.001 0.015 <0.001 
β < 0.001 -0.116 <0.001 
P 0.966 0.604 0.924 
%∆CSA Males ∆R2 0.048 0.034 0.057 
β 0.001 0.058 0.001 
P 0.433 0.511 0.389 
Females ∆R2 0.036 0.018 0.025 
β <0.001 -0.031 0.001 
P 0.436 0.585 0.522 
MVPA – Moderate to vigorous physical activity, BW – Body weight, %∆COMP = Percent 
change in cartilage oligomeric matrix protein, %∆CSA – percent change in knee cartilage 
cross-sectional area 











Figure 5: Experimental design for second laboratory session. Participants rested for 45 minutes 
in a long sit position, the pre-walking measurements of COMP and cartilage CSA were 
measured. Participants walked 3000 steps on a treadmill at a previously measured preferred 
walking speed. Post-walking measurements of COMP and cartilage CSA were measured 
immediately following the standardized walking protocol. 
 
 
Figure 6. Participants placed their head on a marked line at the top of the table and brought their 



















Figure 8. Lesser percent change in cartilage oligomeric matrix protein (%ΔCOMP) associates 







Figure 9. Lesser percent change in cartilage oligomeric matrix protein (%ΔCOMP) associates 
with greater Moderate and Vigorous Physical Activity (MVPA) in Males post- anterior cruciate 







Figure 10. Lesser percent change in cartilage oligomeric matrix protein (%ΔCOMP) associates 
with greater Cumulative Loading in Males post- anterior cruciate ligament reconstruction 
(ACLR). 
BW – Body Weight 
 





Daily Steps, Moderate to Vigorous Physical Activity, and Cumulative Loading Associate with 
Cartilage Biomarkers and Magnetic Resonance Imaging in Individuals with Anterior Cruciate 
Ligament Reconstruction 
Introduction 
 One-third of all individuals who sustain an anterior cruciate ligament (ACL) injury and 
undergo ACL reconstruction (ACLR) will develop posttraumatic osteoarthritis (PTOA) within 
one decade (179), with two-thirds of all individuals developing PTOA within two decades (179). 
While the development of PTOA is complex, aberrant biomechanical loading of joint tissues has 
been hypothesized to play a major role in PTOA pathogenesis (9, 16, 17, 156). Previous studies 
indicate that both excessive (180, 181) and insufficient loading (9, 10, 169) may lead to 
deleterious changes in joint tissue health, suggesting that determining optimal joint loading 
following injury is critical for prescribing effective treatments for preventing PTOA. Changes in 
biomechanical loading of an injured lower extremity joint may be multifaceted; therefore, the 
forces applied to the extremity during a single step as well as the frequency and intensity of steps 
incurred throughout a day should be considered in a comprehensive evaluation of the impact of 
biomechanical loading on joint tissue changes following ACLR. 
 It is well documented that individuals with ACLR often demonstrate persistent alterations 
in walking gait biomechanics (16, 182), which may contribute to the development of PTOA (53, 
183). Specifically, lesser vGRF in the first 6 months following ACLR is associated with greater 
serum concentrations of matrix metalloproteinase -3 (MMP-3) (10), a degenerative enzyme 
related to cartilage breakdown, and greater T1rho magnetic resonance imaging (MRI) relaxation 
times (17), a biomarker of decreased proteoglycan density within the femoral articular cartilage. 
Similarly, lesser tibiofemoral contact forces during gait at 6 months post-ACLR are associated 




reported that greater vGRF is associated with greater T1rho MRI relaxation times (65). These 
studies (10, 17, 65)have only evaluated the magnitude of peak vGRF over a single step, and have 
not accounted for frequency of biomechanical loading, which may account for discrepancies 
between study results. Measuring frequency of biomechanical loading utilizing objectively 
measured physical activity may provide unique information regarding the relationship between 
biomechanical loading and biomarker outcomes related to PTOA. 
 Individuals 27.8±17.5 months post-ACLR demonstrate fewer daily steps and fewer 
minutes in moderate to vigorous physical activity (MVPA) compared to age and sex matched 
uninjured controls (11). Reductions in daily steps and time in MVPA may decrease the 
frequency and volume of biomechanical loading to joint related tissues following ACL. 
Therefore cumulative loading (14, 18), measured as the product of daily steps and a fundamental 
measure of biomechanical loading such as peak vGRF, may be utilized to measure total exposure 
to biomechanical loading, or habitual biomechanical loading. Cumulative loading measured by 
multiplying daily steps and knee adduction moment distinguishes healthy and osteoarthritic 
knees (14). In individuals with ACLR, peak vGRF may be a promising variable to quantify 
cumulative loading as greater peak vGRF in the first 50% of stance associates with patient 
reported outcomes (24, 25), biomarkers of joint tissue metabolism (9, 10, 169), and changes in 
cartilage composition (17). It is unknown how habitual biomechanical loading associates with 
joint tissue metabolism and femoral cartilage composition post-ACLR. Joint tissue metabolism 
and cartilage composition outcomes can detect changes in the articular cartilage prior to 
structural joint changes that can be detected with traditional radiographs (10, 63). Habitual 




magnitude of biomechanical loading and biomarkers of joint tissue metabolism and cartilage 
composition. 
Changes in joint tissue metabolism and cartilage composition have been used to evaluate 
early joint changes associated with the development of early PTOA. Synovial fluid 
concentrations of MMP-3 are elevated in individuals immediately following ACL injury (33), 
and stay elevated for over one-year post-ACLR compared to uninjured controls (109). Cartilage 
Oligomeric Matrix Protein (COMP) is a non-collagenous protein that binds to type-II collagen to 
assist with stabilization, and it is associated with cartilage matrix breakdown (61). Synovial fluid 
COMP is elevated in individuals early following ACLR (105) and remains elevated for years 
following ACLR (61). Increased levels of COMP also associate with early KOA progression 
(164). Both MMP-3 and COMP are biomarkers associated with joint tissue metabolism that 
associate with biomechanical loading (10, 40). In addition to MMP-3 and COMP biomarkers, 
T1rho MRI relaxation times collected with MRI are sensitive to interactions between water and 
proteoglycans (34), and greater T1rho MRI relaxation times have been found to correlate with 
depleted proteoglycan density in bovine (35) and human articular cartilage one year post-ACLR 
(36). Decreased proteoglycan density of the articular cartilage is associated with early PTOA 
progression (37), and T1rho MRI relaxation times are sensitive to changes in biomechanical 
loading (17, 184, 185). It remains unknown if habitual biomechanical loading (daily steps, 
MVPA, and cumulative loading) associates with femoral cartilage composition in individuals 
post-ACLR. The primary purpose of the current study was to determine the association between 
measures of habitual biomechanical loading (i.e. daily steps, MVPA, cumulative loading) and 
outcomes of joint tissue metabolism (MMP-3 and COMP), and cartilage composition (T1rho 




daily steps, greater time in MVPA, and greater cumulative loading would associate with lesser 
MMP-3, indicative of less degenerative enzymatic activity, and lesser T1rho MRI relaxation 




 Individuals with a bone-patellar-tendon-bone ACLR allograft completed three laboratory 
testing sessions on separate days as part of this cross-sectional study. Demographic variables and 
vGRF, which were used to calculate cumulative loading, were collected during the initial 
session. Daily steps and MVPA were assessed using an ActiGraph GT9X Link triaxial 
accelerometer worn outside of the laboratory for a 7-day period, which began immediately 
following the initial session. Resting blood was collected at the beginning of the second session 
(17±12 days after the initial session) and serum was stored for MMP-3 and COMP analysis at the 
end of the study. Lastly, resting T1rho MRI relaxation times were collected on the injured ACLR 
limb followed by the uninjured contralateral limb during the third session (27±22 days after the 
initial session). The Institutional Review Board at our institution approved all methods, and all 
participants provided written consent prior to participation. 
 
Participants 
 We included individuals who underwent unilateral ACLR using a bone-patellar-tendon-
bone autograft within the 6-18 months prior to data collection and had physician approval to 
return to participation in physical activity. Individuals between the ages of 18-35 years with a 




been previously diagnosed with any form of inflammatory arthritis, needed a multi-ligament 
reconstruction, or had a previous history of ACLR on either limb. Individuals were excluded 
from MRI if they had a history of cochlear implant or claustrophobia. Demographic data are 
provided in Table 1. We hypothesized that a moderate association would be detected between 
daily steps, MVPA, cumulative loading, and MMP-3 and COMP based on previous data which 
found a significant association (R2 = 0.29) between knee adduction moment, a measurement of 
biomechanical loading, and MMP-3 in individuals with ACLR (10). Age was included as a 
covariate because age associates with several joint tissue metabolism biomarkers (33, 100). 
Therefore, 35 participants were needed to detect statistical significance for a linear multiple 
regression with an R2 of this magnitude with an alpha level set at 0.05 and 80% power with 1 
covariate (G*Power, v3.1.9.2) (124). We recruited an additional participant (N=36) to maintain 
statistical power in the event an outlier was removed from the final dataset or a data point was 
missing due to the inability to obtain blood samples. We also estimated a moderate association 
would be detected between daily steps, MVPA, cumulative loading, and T1rho MRI relaxation 
time in the femoral cartilage based on previous data evaluating the association (R2 = 0.37) 
between daily steps and change in T1rho MRI relaxation times in uninjured healthy individuals 
(125). Therefore, we needed 26 participants to detect statistical significance for a multiple linear 
regression with an R2 of this magnitude with an alpha level set at 0.05 and 80% power 
(G*Power, v3.1.9.2) (124). We collected T1rho MRI on 26 consecutive participants who 







Vertical Ground Reaction Force  
 vGRF was collected in individuals as walked barefoot at a self-selected speed over two 
Bertec force plates (40x60cm, FP406010, Bertec Corporation, Columbus, Ohio, United States) 
embedded in a 6-meter walkway so the entire stance phase for both the right and left limbs could 
be collected from a single trial (9, 10, 40). Participants were instructed to walk at a self-selected 
speed described as “comfortably walking over a sidewalk” and to look straight ahead 
maintaining a constant speed through two sets of infrared timing gates (TF100, Trac Tronix, 
Lenexa, Kansas) centered on the force plates. Once the participants felt comfortable with the 
task, five practice trials were performed to determine the average walking speed to be used 
during the test trials. During data collection participants performed five gait trials that were 
considered acceptable if: 1) Both right and left feet individually made contact with a single force 
plate for the entirety of stance; 2) A forward gaze was maintained; 3) Consistent gait speed 
(±5%) was maintained; 4) Gait was not visibly altered during the trial (i.e. no tripping or stutter 
stepping). Force data was sampled at 1200 Hz and low pass filtered at 10 Hz (4th order recursive 
Butterworth) (24). Stance was defined as the interval between heel strike (vGRF > 20 N) and toe 
off (vGRF < 20 N). Peak vGRF of each trial was extracted from the first 50% of stance phase 
and then averaged across the five acceptable trials and normalized to body weight (BW).  
 
Objectively Measured Physical Activity 
 At the end of the testing session, participants were given an ActiGraph GT9X Link 
triaxial accelerometer. The ActiGraph GT9X Link is a valid device to quantify physical activity 
in free-living conditions (136, 137). Participants wore the accelerometer over the right anterior 




data collection period was a minimum of 4 days (3 weekdays and 1 weekend day) of wear of no 
less than 10 hours per day (117). The participants returned the monitor after the wear-period, at 
which time the data were assessed for fidelity and consistency with wear guidelines.  
 Average daily steps and time spent in MVPA per day were processed and analyzed using 
ActiLife software (v6.13.3). Total wear time was validated using Choi et al. (117) 
recommendations in order to ensure each participant wore the ActiGraph for at least 4 days for 
10 hours a day.  Freedson Adult VM3 cut points were used to categorize physical activity as light 
(<2690 counts/minute), moderate (2690-6166 counts/minute), vigorous (6167-9642 
counts/minute), or very vigorous (>9642 counts/minute) based on the number of activity counts 
per minute during wear time (138). Cut points were then used to calculate MVPA (>2690 
counts/minute)(138). Daily steps were assessed using vertical acceleration data measured with 
the ActiGraph monitor. Variables were then normalized to the number of wear days to create a 
daily average (11). Cumulative loading was calculated as the product of steps-per-day and peak 
vGRF (Equation 1). 
(1)  𝐶𝑢𝑚𝑢𝑙𝑎𝑡𝑖𝑣𝑒 𝐿𝑜𝑎𝑑𝑖𝑛𝑔 = (
𝐷𝑎𝑖𝑙𝑦 𝑆𝑡𝑒𝑝𝑠
2
) ∗ 𝑝𝑒𝑎𝑘 𝑣𝐺𝑅𝐹 
 
Serum Matrix Metalloproteinase-3 (MMP-3) and Cartilage Oligomeric Matrix Protein Analysis  
 
 Five milliliters of blood were collected via syringe from the antecubital fossa with a 21-
gauge needle. Blood was immediately transferred to a serum separation tube vacutainer. After 
clotting, tubes were placed on ice until centrifuged at 4°C for 10 minutes at 3000 rpm. Serum 
was pipetted equally into four 2.0-mL cryovials and stored in an –80°C freezer for batch analysis 
at the end of the study. Serum was assessed for MMP-3 and COMP via a commercially available 




Specific assay detection sensitivity for MMP-3 was 0.009 ng/mL, and sensitivity for COMP was 
<10 ng/mL. All standards, controls, and samples were performed in duplicate determinations and 
demonstrated intra-assay variability <10%. The average variability of MMP-3 was 1.3±1.2%, 
and the average variability of COMP was 2.9±2.3%.  
 
Magnetic Resonance Image Acquisition 
 T1rho MRI were acquired on the ACLR limb followed by the uninjured contralateral 
limb using a Siemens Magnetom Prisma 3T scanner and a 4-channel Siemens large flex coil (516 
mm x 224 mm, Siemens, Munich, Germany). Upon arrival to the biomedical imaging center, 
participants remained seated for 45 minutes to unload the knee cartilage (102). We used a T1rho 
prepared three-dimensional Fast Low Angle Shot (FLASH) with a spin-lock power at 500Hz, 
five different spin-lock durations (40, 30, 20, 10, 0 ms) and a voxel size of 0.8mm x 0.4mm x 
3mm (field of view= 288mm, slice thickness=3.0mm, 160 × 320 matrix, gap= 0mm, flip 
angle=10°, echo-train duration time= 443ms, phase encode direction of anterior/posterior) (121). 
Before segmentation, an affine registration technique was used to register the ACLR limb image 
to the uninjured limb image using the 3-D Slicer software (122). After the affine registration, a 
nonrigid deformable, voxel-by-voxel intensity-based registration technique was applied to 
account for specific interlimb differences of specific tissues (e.g., bone and cartilage), which 
would ensure an accurate alignment of the ACLR limb to the uninjured limb. 
 
Segmentation of the Articular Cartilage 
 The articular cartilage in the medial and lateral condyles of the femur was manually 




duration.  Manual segmentation of the articular cartilage has demonstrated strong reliability in 
our laboratory for all regions of interest (ROI) (intra-rater reliability, N=8, ICC = 0.80-0.97; 
inter-segmentor reliability, N=10, ICC = 0.75-0.98) (74). The medial and lateral femoral (MFC 
and LFC) were further sub-sectioned into three regions of interest (ROIs), based upon the 
location of the meniscus in the sagittal plane (74). The three ROI that were sub-sectioned 
represent load-bearing regions of the femoral condyle and included: 1) the cartilage overlying the 
posterior horn of the meniscus (Posterior MFC/LFC); 2) the central portion of the cartilage that 
lies between the anterior and posterior horns of the meniscus (Central MFC/LFC); and 3) the 
cartilage corresponding with the anterior horn of the meniscus (Anterior MFC/LFC) (121).  
 
T1rho MRI Relaxation Time Quantification  
 Voxel by voxel T1rho relaxation maps were constructed from a five-image sequence 
using a MatLab program (MatLab R2014b [8.4.0] MathWorks, Natick, MA, USA) with the 
following equation: S(TSL) = S0 exp(-TSL/T1rho), whereTSL is the duration of the spin-lock 
time, S0 is signal intensity when TSL = 0, S is the signal intensity, and T1rho is the T1 
relaxation time in the rotating frame. The previous segmentation image was transposed over the 
T1rho image to establish T1rho MRI relaxation times for each ROI (121). A mean of the T1rho 
MRI relaxation times for each ROI was calculated using the ITK-SNAP software (123). Higher 
T1rho MRI relaxation times are interpreted as tissue consisting of lower proteoglycan density 
(63). We calculated T1rho MRI as an interlimb ratio determined as the T1rho MRI relaxation 
time for the ROI of the ACLR limb normalized to the same ROI in the uninjured contralateral 
limb (T1rho interlimb ratio= ACLR limb/uninjured limb), as described previously (17, 121). 




greater T1rho MRI relaxation times on the ACLR limb as compared with the uninjured 
contralateral limb, indicative of lower proteoglycan density in the ACLR limb. 
 
Statistical Analysis 
 All data was assessed by evaluating boxplots for potential outliers. Data points ≥ 3 
standard deviations from the mean were considered statistical outliers and removed from 
subsequent analyses. Means and standard deviations were calculated for all continuous variables, 
and frequencies were counted for non-continuous variables. Independent t-tests were conducted 
for all demographic, independent, and dependent variables between males and females prior to 
the primary analyses. Age was included as a covariate in all linear regressions where MMP-3 or 
COMP were the dependent variable (128), as age associates with biochemical markers of joint 
tissue metabolism.  
 For the primary analyses, separate stepwise univariate linear regression models were 
constructed to determine the unique associations between habitual biomechanical loading 
variables (daily steps, MVPA, and cumulative loading) and measures of joint tissue metabolism 
(MMP-3 and COMP) and femoral cartilage composition (T1rho MRI interlimb ratios). Separate 
regression equations were constructed using MMP-3, COMP, and T1rho MRI interlimb ratio as 
criterion variables and daily steps, MVPA, with cumulative loading outcomes individually 
evaluated as predictor variables in separate equations. Age was added to each regression 
equation prior to the independent variable of interest. We evaluated the change in R2 (∆R2) and 
unstandardized beta (β) for the criterion variable attributable to each predictor variable after 





Post Hoc Analysis  
 Sex has been shown to influence biochemical markers of joint tissue metabolism 
following ACLR (41, 42). Therefore, as a post hoc analysis, the cohort was stratified by sex, and 
separate regression equations were constructed using MMP-3, COMP, and T1rho MRI interlimb 
ratios as dependent variables and daily steps, MVPA, and cumulative loading were individually 
evaluated as independent variables in separate equations. Age was not included as a covariate in 
the secondary analysis due to small sample size once stratified by sex. We evaluated ∆R2 and β 
in the dependent variable from each independent variable. Statistical significance was 
determined a priori as P ≤ 0.05, and all statistical analyses were performed using the Statistical 
Package for the Social Sciences software (SPSS, Version 21, IBM Corp., Somers, NY).  
 
Results 
 Demographic information, independent variables, and dependent variables for the entire 
cohort, as well as males and females, are shown in Table 1 and Table 2. No outliers within the 
entire cohort were identified for any of the independent or dependent variables. Within our entire 
cohort (n=36), males demonstrated greater age (t34=2.80,P=0.009), height (t34=6.59,P<0.001), 
mass (t34=3.93,P<0.001), MMP-3 (t34=9.90,P<0.001), and time in MVPA (t34=2.05,P=0.048) 
compared to females (Table 2). In the 26 individuals in whom we obtained an MRI (n=26), 
males demonstrated greater age (t24=2.92,P=0.007), height (t24=5.35,P<0.001), mass 
(t24=3.79,P=0.001), months post-ACLR (t24=2.43,P=0.023), MMP-3 (t24=7.52,P<0.001), T1rho 
MRI relaxation times in the anterior MFC (t24=2.42,P=0.024), central LFC (t24=2.17,P=0.040), 
and posterior LFC in the involved limb (t24=3.88,P=0.001), and greater T1rho MRI interlimb 




Primary Analyses – Associations within the Entire Cohort 
 Greater concentrations of MMP-3 associated with greater minutes spent in MVPA 
(∆R2=0.152, β=0.135, P=0.015, Table 3, Figure 1). Greater T1rho MRI interlimb ratios for the 
central LFC ROI associated with greater MVPA (∆R2=0.178, β=0.002, P=0.032, Table 3, Figure 
2). No significant associations existed between MMP-3 and daily steps (∆R2=0.01, β<0.001, 
P=0.549, Table 3) or cumulative loading (∆R2=0.029, β=0.001, P=0.305, Table 3). No 
significant associations existed between MVPA and T1rho MRI interlimb ratios for all other 
ROIs (∆R2 range < 0.001 – 0.118, P>0.05, Table 3). No significant associations existed between 
T1rho MRI interlimb ratios and daily steps (∆R2 range < 0.001 – 0.071, P>0.05, Table 3) or 
cumulative loading (∆R2 range < 0.001 – 0.072, P>0.05, Table 3). No significant associations 
existed between COMP and daily steps, MVPA, or cumulative loading (R2 range = 0.001 – 
0.024, P>0.005, Table 3). 
 
Post Hoc Analysis – Associations in Males and Females 
Male Subgroup 
 Greater daily steps associated with greater T1rho MRI interlimb ratios in the posterior 
MFC (R2=0.574, β<0.001, P=0.011, Table 3), central MCF (R2=0.639, β<0.001, P=0.006, Table 
3), and anterior MFC (R2=0.661, β<0.001, P=0.004, Table 3). Greater MVPA associated with 
greater anterior LFC (R2=0.497, β=0.002, P=0.023, Table 3), posterior MFC (R2=0.450, 
β=0.002, P=0.034, Table 3), central MFC (R2=0.713, β=0.003, P=0.002, Table 3), and anterior 
MFC (R2=0.753, β=0.003, P=0.001, Table 3) T1rho MRI interlimb ratios. Greater cumulative 
loading associated with greater posterior MFC (R2=0.619, β< -0.001, P=0.007, Table 3), central 




Table 3) T1rho MRI interlimb ratios. COMP (R2 range = 0.002 – 0.059, P>0.05, Table 3) and 
MMP-3 (R2 range=0.043 – 0.082, P>0.05, Table 3) did not associate with daily steps, MVPA, or 
cumulative loading in males (). 
 
Female Subgroup 
 Fewer daily steps associated with greater posterior MFC (R2=0.304, β< -0.001, P=0.027, 
Table 3) and central MFC (R2=0.276, β< -0.001, P=0.037, Table 3) T1rho MRI interlimb ratios 
in females. There was no association between T1rho MRI interlimb ratios and MVPA in females 
(R2 range = <0.001 - 0.120, P>0.05, Table 3). Lesser cumulative loading associated with greater 
posterior MFC (R2=0.309, β= < -0.001, P=0.025, Table 3) and central MFC (R2=0.292, β< -
0.001, P=0.031, Table 3) interlimb ratios in females. All other T1hrho interlimb ratios did not 
associate with daily steps, MVPA, or cumulative loading in males or females (R2 range = <0.001 
– 0.354, P>0.05, Table 3). COMP (R2 range = 0.009 – 0.022, P>0.05, Table 3) and MMP-3 (R2 




Contrary to our primary hypotheses, greater MMP-3 and greater T1rho MRI interlimb 
ratio in the central LFC associated with greater time in MVPA, suggesting greater habitual 
biomechanical loading associates with greater degenerative enzymatic activity and lesser 
proteoglycan density in individuals post-ACLR. Daily steps and cumulative loading did not 
associate with MMP-3, COMP, or T1rho MRI interlimb ratios within the entire cohort. We 




lesser MMP-3 and T1rho MRI interlimb ratios, while males who engaged in greater daily steps, 
time in MVPA, and cumulative loading demonstrated greater MMP-3 and T1rho MRI interlimb 
ratios. Excessive time spent in MVPA may be detrimental early following ACLR, particularly in 
males. Results from the current study support the need for personalized strategies and targets for 
habitual biomechanical loading early following ACLR. 
This is the first study to our knowledge to evaluate the association between measures of 
habitual biomechanical loading and biomarkers of joint tissue metabolism and cartilage 
composition. Associations have previously been demonstrated between greater vGRF and lesser 
MMP-3 (10) and lesser T1rho MRI interlimb ratios (17) one year post-ACLR. The entire cohort 
was 8±2 months post-ACLR and participated in 61±23 minutes per day of MVPA, or 
approximately 7 hours/ per week of MVPA. Physical activity recommendation guidelines 
suggest healthy adults engage in a minimum of 2.5 hours per week of MVPA (149). Our cohort 
was participating in a high amount of MVPA at the time of testing. Lack of participation in 
physical activity is a nation-wide concern (149), causing increased mortality and morbidity for 
multiple diseases including cardiovascular disease, cancer, and type 2 diabetes mellitus (97). 
However, ACLR often occurs in young, active, and athletic individuals (186), so it is possible 
our current cohort participated in high levels of physical activity, which is not usually a concern 
in other populations (i.e. older adults, cancer patients) (96, 134). Males in the current cohort 
participated in less time in MVPA compared to uninjured controls of similar age and BMI 
reported in a previous study (94±22 minutes per day), (11) indicating the high levels of MVPA 
reported in our cohort, while not excessive, may be not beneficial to the articular cartilage. Both 
excessive (65, 187) and insufficient (10, 17) biomechanical loading following ACLR may have 




in the current study may have contributed to excessive loading of the articular cartilage within 
the first 12 months following ACLR. Therefore, the relationship between greater MVPA and 
more deleterious biomarker and T1rho MRI outcomes, which was contrary to our hypothesis, 
may be influenced by the overall greater MVPA in which males engaged. Females in the current 
cohort participated in lesser MVPA compared to the males, and subsequently demonstrated a 
relationship between lesser MVPA and worse joint tissue metabolism and T1rho MRI outcomes, 
which was consistent with our initial hypothesis. Therefore, baseline MVPA may be a critical 
factor in demining the nature of the relationship between MVPA and joint tissue metabolism and 
T1rho MRI outcomes.  
 Within our entire cohort, greater MMP-3 associated with greater MVPA, while COMP 
did not significantly associate with any measures habitual biomechanical loading. MMP-3 and 
COMP are elevated at different time points following ACLR, and likely reflect different 
processes of joint tissue metabolism.  MMP-3 was utilized in the current study because it 
remains elevated for at least one year following ACLR (128). MMP-3 is one of the major 
pathways involved in proteoglycan degradation (60), which is associated with early signs of 
cartilage breakdown (37). As mentioned previously, our entire cohort demonstrated high 
amounts of time in MVPA; therefore, it remains unknown if greater degenerative enzymes would 
associate with greater time in MVPA in a less physically active group of individuals. While a 
moderate amount of biomechanical loading is necessary to maintain healthy joint tissue 
metabolism (12, 88, 188); however our results suggest that excessive time in MVPA during the 
first 12 months following ACLR may be associated with degenerative processes related to 
cartilage breakdown. The current study measured serum MMP-3 rather than synovial fluid 




enzymatic activity as well as enzymatic activity in other cartilaginous tissues. MMP-3 also plays 
a critical role in cleaving muscle-specific proteins and assisting in extracellular matrix formation 
and hypertrophy (189). High levels of biomechanical stress, particularly high-intensity exercise, 
may activate production of MMP-3 (190, 191). Elevated MMP-3 may not be exclusively due to 
cartilage breakdown in an active group of individuals, like the current cohort. MMP-3 is slightly 
elevated immediately following high-intensity exercise such as running (190), and it is possible 
elevated MMP-3 in the current cohort is not indicative of long-term joint health.  
 COMP is a biochemical marker that binds with type-II collagen in the extracellular 
matrix and is elevated in early stages of PTOA (61). Higher COMP also associates with 
progression of KOA (164). In the current study, COMP concentrations did not associate with 
habitual biomechanical loading. MMP-3 is elevated immediately following ACLR and decreases 
within one year post-ACLR (107), while COMP remains elevated longer following ACLR (61) 
and remains elevated in individuals with KOA (164).  Greater serum COMP is related to greater 
type-II collagen breakdown (61), and type-II collagen alterations are not present until after 
alterations in proteoglycan density occur (50). In the current study, COMP concentrations may 
not yet be elevated, since participants were only 8±2 months post-ACLR. Future studies may 
evaluate COMP in a cohort who are greater than 8±2 months post-ACLR.  
 In the current study, greater MVPA associated with greater T1rho MRI interlimb ratios in 
the central LFC. It is possible that greater time in MVPA associated with greater T1rho MRI 
interlimb ratios in the central LFC due to traumatic bone marrow-like edema lesions that often 
occur on the anterior and central portions of the LFC during ACL injury (192). ROIs of the 
femur that correspond to portions of the bone that experience traumatic bone marrow-like edema 




also be more susceptible to higher intensity of biomechanical loading experienced during more 
time engaged in MVPA. Due to the cross-sectional nature of the study, it remains unknown how 
time spent in MVPA changes throughout ACLR rehabilitation. It is possible some participants in 
our study began engaging in high levels of MVPA too soon after ACLR, leading to worse T1rho 
MRI relaxation time outcomes. Future studies should longitudinally evaluate MVPA and 
cartilage composition during ACLR rehabilitation. 
 Males who engaged in greater daily steps, MVPA, and cumulative loading demonstrated 
greater T1rho MRI interlimb ratios, or lesser proteoglycan density, predominately in the MFC 
ROI. Females who engaged in greater daily steps and cumulative loading demonstrated lesser 
T1rho MRI interlimb ratios, or greater proteoglycan density, in the central and posterior MFC 
ROIs. Based on results from the current study, females may benefit from therapeutic 
interventions that increase habitual biomechanical loading early following ACLR. Conversely, 
males may benefit from reducing habitual biomechanical loading early following ACLR. Our 
data suggest that a slightly different therapeutic strategy may need to be conducted with males as 
an increase in MVPA may result in a deleterious change in T1rho and MMP-3. In the current 
study, males who obtained an MRI engaged in 69±21 MVPA minutes per day compared to 
females who participated in 54±23 MVPA minutes per day (moderate effect size, Cohen’s 
d=0.60). These differences in MVPA were not statistically significant, likely due to a small 
sample size (n=26). Males also demonstrated significantly greater concentrations of MMP-3 
(21.2±5.6 ng/mL) compared to females (7.5±2.4 ng/mL). Differences in MVPA and MMP-3 
may have influenced the different associations found between males and females in the current 
study. It remains unclear if increasing daily steps and cumulative loading in males, while not 




times. Additionally, it remains unclear if the sex differences that we found for the associations 
between habitual biomechanical loading and with T1rho MRI interlimb ratios is unique to our 
cohort. Future studies should determine if MVPA may be a stronger predictor than sex in 
determining effects of daily steps and cumulative loading on MMP-3 and T1rho MRI relaxation 
times.  
 
Response to Manuscript 2 Results 
 In manuscript 2, males who engaged in greater daily steps, greater time in MVPA, and 
greater cumulative loading demonstrated a smaller change in serum COMP concentration 
immediately following a standardized walking protocol. There were no significant associations 
in females. In the current study, greater MVPA associated with greater resting MMP-3 
concentrations and greater T1rho MRI interlimb ratios. Overall, manuscript 2 suggests greater 
MVPA associates with a more conditioned response to a standardized walking protocol in males. 
COMP is non-collageneous protein that binds to type-II collagens to increase stability in the 
extracellular matrix and resist deformation to biomechanical loading (194). Concentrations of 
type-II collagen breakdown biomarkers are elevated within one-year post-ACLR (195), and type-
II collagen breakdown is also elevated in individuals diagnosed with KOA (164). Participants in 
the current study were 8±2 months post-ACLR, and type-II collagen may not undergo 
degenerative changes this early following ACLR. Manuscript 3 evaluated MMP-3, an enzyme 
heavily involved in proteoglycan degradation immediately following ACLR (33, 107). MMP-3 
typically remains elevated between 6 (107) and 12 months following ACLR (33). It is possible 
that individuals who engage in greater MPVA may experience higher concentrations of MMP-3, 




experiencing lesser COMP response. COMP response may be affected in individuals greater than 
8±2 months post-ACLR when alterations in type-II collagen organization begin (194). MMP-3 
likely reflects processes related to early cartilage matrix breakdown (107), while COMP likely 
reflects processes associated with later stages of cartilage matrix degradation (61). Results from 
Manuscript 2 and Manuscript 3 suggest that habitual biomechanical loading may affect 
proteoglycans and type-II collagens differently based on time from ACLR. These studies 
highlight the need for additional research and longitudinal studies which evaluate habitual 
biomechanical loading and multiple markers of joint tissue metabolism throughout the ACLR 
rehabilitation process.  
 
Limitations 
 The current study is the first to demonstrate associations between MMP-3, T1rho MRI 
interlimb ratios, and daily steps, time in MVPA, and cumulative loading in individuals post-
ACLR. However, there are some limitations that could better inform future studies. Age, height, 
and mass were significantly different between males and females (Table 1), but due to our small 
sample size, we did not include these outcomes as covariates in the linear regression models to 
maintain adequate power. Our sample size was small, and results from the current study suggest 
future research should evaluate sex differences in habitual biomechanical loading and biomarker 
and MRI outcomes of knee cartilage health in larger sample sizes. Rather than knee synovial 
fluid, we measured MMP-3 from serum, which can be influenced by systemic alterations in 
MMP-3 rather than knee specific changes. Our design was cross-sectional, so it is unknown if 








 Overall, greater time in MVPA associates with greater serum concentration of MMP-3, 
and greater T1rho interlimb ratios in the central LFC ROI in individuals post-ACLR. Males who 
engage in greater daily steps, greater time in MVPA, and greater cumulative loading demonstrate 
greater T1rho MRI interlimb ratios in the MFC and central LFC ROI. Females who engaged in 
greater daily steps and cumulative loading demonstrated lesser T1rho MRI interlimb ratios, in 
the central and posterior MFC ROI. Habitual biomechanical loading is an important factor to 
consider when determining optimal biomechanical loading in individuals with ACLR, as both 
excessive and insufficient biomechanical loading may be detrimental following ACLR. These 
results suggest that sex plays a role in the association between habitual biomechanical loading 
and biomarkers of joint tissue metabolism and composition early following ACLR. There is a 
need to longitudinally evaluate habitual biomechanical loading and biomarkers of joint tissue 





Table 14. Demographic, Independent, and Dependent Variables 






Age (years) 22±4 24±5 20±3 * 
Height (m) 1.71±0.10 1.78±0.08 1.64±0.05 * 
Mass (kg) 71.6±12.4 79.2±11.5 65.5±9.5 * 
Body Mass Index (kg/m2) 24.5±2.8 24.8±2.2 24.3±3.3 
Months post-ACLR 8±2 9±2 8±3 
MMP-3 concentration (ng/mL) 13.55±8.00 21.2±5.6 7.5±2.4 * 
COMP concentration (ng/mL) 151.3±48.1 158.2±54.8 145.8±42.7 
Daily steps 7781±2247 7930±2100 7662±2405 
Moderate-Vigorous Physical Activity 
(minutes/day) 
61±23 69±21 54±23 * 
Vigorous Physical Activity 
(minutes/day) 
6±6 8±7 5±6 
Cumulative Loading (BW/day) 4112±1257 4274±1168 3982±1339 
ACLR – anterior cruciate ligament reconstruction, MMP-3 – matrix metalloproteinase-3 





Table 15. Demographic, Independent and Dependent Variables – Participants with MRI 
 Entire Cohort 
(N=26) 
Males (n=10) Females 
(n=16) 
Age (years) 21±4 24±5 19±3 * 
Height (m) 1.70±0.10 1.79±0.09 1.64±0.06 * 
Mass (kg) 72.0±13.3 82.1±12.5 65.6±9.6 * 
Body Mass Index (kg/m2) 24.9±2.9 25.5±2.0 24.5±3.4 
Months post-ACLR 8±1 9±2 7±1 * 
MMP-3 concentration (ng/mL) 12.19±7.34 19.8±5.9 7.4±2.4 * 
COMP concentration (ng/mL) 152.4±53.7 157.2±66.7 149.3±45.8 
Daily steps 7678±2327 7968±2421 7496±2328 
Moderate-Vigorous Physical Activity 
(minutes/day) 
59.6±25.4 69±25 54±25 
Cumulative Loading (BW/day) 4051±1335 4234±1371 3938±1345 
Anterior MFC 
MRI T1rho ILR 
Involved (ms) 58.2±4.6  60.7±2.8 56.6±4.9 * 
Contralateral 
(ms) 
53.9±3.4 54.3±3.3 54.6±3.6 
Interlimb ratio 1.08±0.09 1.12±0.08 1.06±0.10 
Central MFC 
T1rho MRI ILR 
Involved (ms) 55.3±4.3 56.6±3.7 54.6±4.5 
Contralateral 
(ms) 
51.9±3.9 52.6±2.7 51.4±4.4 
Interlimb ratio 1.07±0.11 1.08±0.09 1.07±0.12 
Posterior MFC 
MRI T1rho ILR 
Involved (ms) 54.9±3.7 55.6±2.9 54.4±4.1 
Contralateral 
(ms) 
52.9±3.0 53.6±3.0 52.5±3.1 
Interlimb ratio 1.04±0.08 1.04±0.07 1.04±0.09 
Anterior LFC 
MRI T1rho ILR 
Involved (ms) 56.1±4.5 57.1±2.2 55.5±5.5 
Contralateral 
(ms) 
49.8±4.3 49.9±3.3 49.8±4.9 
Interlimb ratio 1.13±0.11 1.15±0.08 1.12±0.13 
Central LFC MRI 
T1rho ILR 
Involved (ms) 55.4±4.2  57.5±3.7 54.1±4.0 * 
Contralateral 
(ms) 
53.0±3.7 53.1±3.8 52.8±3.8 
Interlimb ratio 1.05±0.10 1.09±0.13 1.03±0.08 
Posterior LFC 
MRI T1rho ILR 
Involved (ms) 56.2±4.1 59.3±2.5 54.2±3.7 * 
Contralateral 
(ms) 
55.3±3.6 56.0±3.9 54.8±3.5 
Interlimb ratio 1.02±0.09 1.06±0.10 0.99±0.08 * 
ACLR – anterior cruciate ligament reconstruction, MMP-3 – matrix metalloproteinase-3, 
COMP – cartilage oligomeric matrix protein, BW – body weight, MRI – magnetic resonance 
imaging, MFC – medial femoral condyle, LFC – lateral femoral condyle, ILR- interlimb ratio 
 







Table 16. Associations Between Habitual Biomechanical Loading, MMP-3, COMP, and T1rho Interlimb Ratios in Individuals with 
ACLR 
 Daily Steps MVPA (minutes) Cumulative Loading (BW/day) 
 Entire 
Cohort 
Males Females Entire 
Cohort 













































































































































































































































P=0.190 β= <0.001 
P=0.376 
















































ACLR – anterior cruciate ligament reconstruction, MMP-3 – matrix metalloproteinase-3, COMP – cartilage oligomeric matrix 
protein, BW – body weight, MRI – magnetic resonance imaging, MFC – medial femoral condyle, LFC – lateral femoral condyle, 
ILR – interlimb ratio 
 






Figure 11. Greater minutes in moderate to vigorous physical activity (MVPA) associates with 
higher concentration of matrix metalloproteinase – 3 (MMP-3; ng/mL) in individuals with an 
anterior cruciate ligament reconstruction (ACLR). 






Figure 12. Greater minutes in moderate-vigorous physical activity (MVPA) associates with 
greater T1rho interlimb ratios in the central lateral femoral condyle (LFC) in individuals with an 
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